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Background and Purpose: Delayed cerebral ischemia (DCI) and Hunt and Hess (HH) grade are 
known risk factors for poor outcomes after aneurysmal subarachnoid hemorrhage (aSAH). DCI 
is often attributed to focal perfusion deficit (vasospasm/infarction). Global perfusion deficit (e.g. 
inadequate cerebral perfusion pressure (CPP)) can impair cerebral blood flow (CBF). The 
relationship between CPP and DCI remains unclear. Further, the exact mechanism of how HH 
grade relates to poor outcomes is uncertain. This study aimed to describe the temporal profiles of 
CPP change and to investigate the relationship between CPP, DCI, HH, and post-aSAH 
outcomes. Method: DCI was defined as clinical deterioration due to impaired CBF. Growth 
curve analysis was used to examine temporal profiles of CPP change. Logistic regression was 
utilized to examine the association between DCI and percentages of CPP values >110, >100, 
<70, and <60 mmHg. The associations between minimum CPP (measured 12 hours prior to 
DCI), DCI, and DCI onset, were tested using logistic regression and accelerated failure time 
model. The mediation effect of DCI on the relationship between HH and outcomes was tested 
using bootstrap confidence interval. Outcomes were assessed at 3 and 12 months and included: 
mortality, neuropsychological, functional, and physical outcomes. Results: There was a 
significant linear increase in CPP over time (β =0.06, SE=0.006, p<0.001). The covariance (-
0.52) between the initial CPP and the linear change parameter was negative indicating that 
subjects with high CPP had a slower rate of increase and those with low CPP had a faster rate 
Evaluating Indices of Delayed Cerebral Ischemia and Poor Outcomes after Subarachnoid 
Hemorrhage: The Role of Cerebral Perfusion Pressure in Disease Pathogenesis 
 
Khalil M. Yousef, RN, MSN, PhD 
University of Pittsburgh, 2013
 
 v 
(p<0.001). For every 10% increase in the proportion of CPP>100 or >110 mmHg, the odds of 
DCI increased by 1.21 and 1.43, respectively. For every 10 mmHg increase in CPP, the odds of 
DCI increased by 2.78 (95%CI 2.00-3.87). High CPP was associated with earlier onset of DCI 
(p<.001). DCI did not mediate the relationship between HH and outcomes. Conclusions: When 
used prophylactically, induced hypertension contributes to higher CPP values. Based on the CPP 
trends/correlations observed, induced hypertension may not confer expected benefits in patients 
with aSAH. Findings raise concerns about safety of induced hypertension and the need for 
determining limits for hypertension, which current guidelines lack. 
 vi 
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1.0  INTRODUCTION 
1.1 INCIDENCE, PREVALENCE, AND FATALITY 
Subarachnoid hemorrhage (SAH) is a sub-type of stroke defined by bleeding in the subarachnoid 
space where cerebrospinal fluid (CSF) circulates (Suarez, Tarr, & Selman, 2006). It represents 
5% of all strokes and 25% of hemorrhagic strokes, affecting more than 30,000 North Americans 
each year with an annual cost to the United States of more than 1.7 billion dollars (Bederson et 
al., 2009; Graf & Nibbelink, 1974; Singer, Ogilvy, & Rordorf, 2011a; Wiebers, Torner, & 
Meissner, 1992). The most common cause for spontaneous SAH is aneurysm rupture (aSAH). 
The annual incidence of aSAH per 100,000 of population varies among different countries: 4.2 in 
South and Central America (lowest), 10 in North America, 12.4 in Sweden, 19.7 in Finland, and 
21.9 in Japan (the highest). Overall, the annual worldwide incidence of aSAH is 9 per 100,000 of 
population (de Rooij, Linn, van der Plas, Algra, & Rinkel, 2007; King, 1997; Koffijberg et al., 
2008). Ethnicity and gender have both been shown to be risk factors for aSAH. Previous studies 
report that the risk for aSAH in African Americans is 2.1 times the risk in Whites (Broderick, 
Brott, Tomsick, Huster, & Miller, 1992), and the risk for females is 1.6 times that of males 
(Lindsay, Teasdale, & Knill-Jones, 1983).  
aSAH is often fatal and, for those who survive, is associated with severe morbidity and 
mortality which ranges between 32-67% (Hop, Rinkel, Algra, & van Gijn, 1997). The fatality 
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rate is particularly high for such a young patient population (mean age = 54 years) (Yousef, 
Crago, Kuo, Horowitz, & Hravnak, 2010). Those who survive the initial insult often suffer 
devastating inpatient and post-discharge complications. Common inpatient complications include 
increased intracranial pressure (ICP), cerebrovascular vasospasm, delayed cerebral ischemia 
(DCI), re-bleeding, hydrocephalus, seizure, electrolyte imbalance, and myocardial injury (Singer 
et al., 2011a). Complications continue after discharge and include moderate to severe physical 
disability, cognitive impairment, and even death (Frontera et al., 2009; Naidech et al., 2005). 
These complications can cause a significant impact on patients’ ability to return to pre-stroke 
functioning and also increase costs for an already overburdened healthcare system. Thus, 
successful monitoring and interventions based on early detection and prevention of 
complications are vital to improving survivors’ physical and neuropsychological function. 
1.2 COMPLICATIONS POST SAH 
Mortality and severe morbidity post aSAH are most commonly associated with DCI (Frontera et 
al., 2009). The Neurocritical Care Society’s recent consensus definition characterizes DCI as 
“neurological deterioration represented by focal deficits (e.g., hemiparesis and/or aphasia) or 
global deficits (e.g., decrease in level of consciousness) related to cerebral ischemia that last for 
more than one hour and cannot be attributed to other radiographic, electrophysiologic or 
laboratory abnormalities” (Diringer et al., 2011; Vergouwen, Vermeulen, et al., 2010). DCI is 
associated with both systemic and neurological complications including septicemia, pneumonia, 
myocardial infarction and clinically significant arrhythmias, pulmonary edema, fever, and 
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cerebral edema (Frontera et al., 2009). Furthermore, DCI is associated with increased impairment 
in activities of daily living, cognitive impairment, poor quality of life, and severe disability and 
death (modified Rankin score 4-6) (Frontera et al., 2009; Springer et al., 2009). Thus, the 
prevention of DCI is key to improving outcomes after aSAH.  
DCI occurs when impairment in cerebral blood flow (hypoperfusion) affects metabolism, 
which has been noted in patients with aSAH (Cahill, Calvert, & Zhang, 2006; Frontera et al., 
2009; A. P. Huang et al., 2010). DCI-related cerebral hypoperfusion can occur locally (i.e., in 
only one part of the cerebral tissue) due to focal vascular alterations such as vasospasm and 
mircothrombi or globally due to pressure/flow deficits such as inadequate cerebral perfusion 
pressure (CPP). Current interventions focus on treatment of local vascular changes 
(cerebrovascular vasospasm and infarction), yet these interventions have had limited success 
(Rinkel & Klijn, 2009). Attempts to prevent cerebrovascular vasospasm and microthrombi using 
endothelin antagonists and antiplatelet administration did not result in a significant reduction in 
DCI or improvement in outcomes post aSAH (Dorhout Mees, van den Bergh, Algra, & Rinkel, 
2007, 2008; A. Kramer & Fletcher, 2009; Macdonald et al., 2008; van den Bergh et al., 2006; 
van den Bergh, Kerr, Algra, Rinkel, & Molyneux, 2009). This lack of effectiveness may be due 
to the fact that one-half of all patients with vasospasm do not develop DCI (Dankbaar et al., 
2009). In fact, studies have indicated that most patients with moderate to severe angiographic 
vasospasm are asymptomatic (i.e., do not develop neurological deterioration) (Vergouwen, 
Ilodigwe, & Macdonald, 2011), suggesting that vasospasm and DCI are not strongly associated 
and therefore treatment of focal perfusion deficits may be insufficient to prevent DCI.  
Few studies have investigated the impact of ICP and mean arterial pressure (MAP) after 
aSAH, however, they did not include DCI per se as an end point and thus they are not sufficient 
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to well establish the impact of global hypoperfusion on DCI. Soehle et. al. suggested that ICP 
and MAP have a stronger influence on outcomes than vasospasm and that elevated MAP is 
significantly associated with poor outcomes after aSAH (Soehle, Chatfield, Czosnyka, & 
Kirkpatrick, 2007). Elevated ICP has also been found to be associated with cerebral ischemia, 
poor outcomes, high mortality, and clinical deterioration in other patient populations and lower 
cerebral perfusion pressure (CPP) has been associated with clinical deterioration after aSAH, yet 
studies to date have not investigated the pathogenesis through which cerebral perfusion affects 
outcomes (Cormio et al., 2001; Ryttlefors, Howells, Nilsson, Ronne-Engstrom, & Enblad, 2007). 
Collectively the data support the combination of ICP and MAP values captured by CPP as an 
important predictor of DCI and subsequent poor outcomes after aSAH.  However, the association 
between changes in CPP and poor outcomes after aSAH has not been well established, nor has 
the role of DCI as a mediator between the two factors. For example, to date, no studies have been 
found that investigated the relationship between CPP and neuropsychological outcomes.  
The novel evaluation of both global and regional causes of impaired cerebral blood flow 
will better elucidate the underlying pathogenesis of DCI and poor outcomes. This will potentially 
improve our ability to design monitoring and interventional approaches to early detect and 
prevent DCI and improve patient outcomes. This study will explore the relationships between 
minimum CPP values, DCI, and outcomes after aSAH. Evaluating this relationship is vital to 
inform current bedside treatment protocols through assessing whether CPP-directed monitoring 
and interventions would help to predict and prevent DCI and subsequent poor patient outcomes.  
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1.3 PURPOSE 
The purpose of this study is to investigate the relationship between CPP, DCI and outcomes after 
aSAH. 
1.4 SPECIFIC AIMS AND HYPOTHESES  
1. To describe and examine CPP changes during the 14 days after aSAH in regard to: 
a. baseline, absolute values, daily changes (range, mean, standard deviation), 
proportion of CPP values <70 mmHg, and proportion of CPP values >100 
mmHg. 
b. trends of CPP values over time. 
Hypothesis 1b: CPP values will change significantly over time.  
2. To examine the relationship between DCI and the lowest decrement in CPP during the 
12 hours prior to DCI. 
a. To examine the association between DCI and the lowest decrement in CPP 
during the 12 hours prior to DCI controlling for Hunt and Hess grade and 
aneurysm repair method. 
Hypothesis 2a: DCI will be associated with the minimum CPP measured 12 hours 
prior to onset of DCI. 
b. To explore the threshold of CPP value associated with DCI.  
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c. To determine whether minimum CPP values are related to the onset of DCI 
controlling for Hunt and Hess grade and aneurysm repair method. 
Hypothesis 2c: Minimum CPP values will be associated with the onset of DCI. 
3. To determine whether DCI mediates the relationship between Hunt and Hess grade 
and neuropsychological outcomes, functional outcomes, physical outcomes, and death 
post aSAH controlling for age, aneurysm repair method, years of education, anxiety 
and depression. 
Hypothesis 3: DCI will partially mediate the relationship between Hunt and Hess grade and 
poor outcomes.  
1.5 DEFINITION OF TERMS 
1.5.1 Independent variables  
1.5.1.1 Cerebral perfusion pressure (CPP) 
CPP is the pressure gradient between mean arterial pressure (MAP) and ICP that allows blood to 
flow to the brain and is measured in mmHg (Alvarez del Castillo, 2001). The standards of care in 
the setting of this study include CPP measurement every two hours, thus a minimum of 12 values 
of CPP each day were available. However, subjects who exhibited neurologic or systemic 
instability had more nursing surveillance and thus more CPP values until stabilized. CPP values 
were included in the analysis as follows:  
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1. In specific aim #1a: absolute values, baseline, maximum, minimum, mean, standard 
deviation of CPP will be used in addition to the percentage of CPP values <70 mmHg, 
and the percentage of CPP values >100 mmHg. 
2. In specific aim #1b: all CPP value measured during the 14 days post injury will be used 
3. In specific aim #2 (a, b, and c): minimum CPP values measured during the 12 hours prior 
to the time of DCI diagnosis will be used.   
1.5.1.2 Delayed cerebral ischemia (DCI) 
DCI is defined as neurological deterioration represented either as focal neurologic deficit (i.e. 
hemiparesis, aphasia, apraxia) or global neurologic deficit (decrease in level of consciousness) 
that lasts for more than one hour and cannot be attributed to other radiographic, 
electrophysiologic or laboratory abnormalities (Diringer et al., 2011; Vergouwen, Vermeulen, et 
al., 2010). In this study, DCI was defined as neurologic deterioration accompanied by abnormal 
cerebral blood flow and cannot be explained by other abnormalities such as hydrocephalus, re-
bleeding, seizure, and cerebral edema (Crago et al., 2011; Yousef et al., 2010).  
1.5.1.3 Hunt and Hess (HH) grade   
Hunt Higher bleeding severity grade measured by Hunt and Hess scale is associated with poor 
outcomes post aSAH (Kreiter et al., 2002; Otawara et al., 2009).  It is unknown if the DCI 
mediates this relationship between Hunt and Hess grade and outcomes. Specific aim #3 tested 
whether the relationship between Hunt and Hess grade and post-aSAH outcomes is mediated by 
DCI.  
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1.5.2 Dependent variables 
1.5.2.1  Subject Outcomes 
Subject outcomes were measured in the areas of physical and neuropsychological health at 3 and 
12 months post aSAH.  Physical health includes subjective assessments of physical functioning, 
disability and objective measures of survival. The following are the domain examined in the 
parent study and included in the current study: attention, learning and memory, psychomotor 
speed, mental flexibility, executive function, visuospatial ability, and language. All test scores in 
all domains were standardized and converted to z scores. Patients with a z score of ≤ -1.5 in more 
than one test or patients with z score ≤ -2.0 in at least one test were considered to have 
impairment in neuropsychological funsction (Wefel et al., 2004). This comprehensive set of 
measurements potentially elicit the true status of aSAH patients after discharge. 
1.5.3 Potential confounding variables  
As potential confounders, the following variables were controlled for in this analysis:  
I) Mood was assessed via depressive symptoms and anxiety. Patients with depression and 
anxiety have worse scores on neuropsychological tests suggesting an increased 
neuropsychological impairment in those patients compared to those without depression or 
anxiety (Basso et al., 2007; Castaneda, Tuulio-Henriksson, Marttunen, Suvisaari, & Lonnqvist, 
2008). Thus, controlling for depression and anxiety was warranted when measuring 
neuropsychological outcomes (Specific Aim #3) in order to ensure that the relationship between 
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CPP, DCI, and poor neuropsychological function outcomes is not confounded by depressive 
symptoms/anxiety.  
II) Age: older age has been associated with poor neuropsychological and functional outcomes in 
patients with aSAH (Haug et al., 2010; Kreiter et al., 2002; Ohwaki et al., 2006). Therefore, age 
was controlled for when testing neuropsychological and functional outcomes (Specific Aim #3) 
to ensure that the relationship between CPP, DCI, and outcomes is not confounded by age.  
III) Years of education: having fewer years of education is associated with poor 
neuropsychological function in aSAH patients (Haug et al., 2010; Kreiter et al., 2002). Therefore 
controlling for number of years of education in Specific Aim #3 is important to make certain that 
these differences between subjects are due to neuropsychological impairment and not due to 
different levels of education.  
IV) Hunt and Hess scale: higher bleeding severity grade measured by Hunt and Hess scale is 
associated with DCI (Frontera et al., 2009) and neuropsychological dysfunction (Kreiter et al., 
2002; Otawara et al., 2009) and thus was controlled for to ensure that the relationship between 
CPP, DCI, and outcomes is not confounded by Hunt and Hess grade. Others have previously 
controlled for Hunt and Hess in similar analysis (Frontera et al., 2009). Hunt and Hess grade was 
controlled for in specific aims #2. 
V) Aneurysm repair method: surgical clipping and endovascular coiling are the major methods 
for treatment intracranial aneurysms. Evidence suggests that the incidences of death, poor 
outcomes, and DCI are higher among those who have surgical clipping (Dorhout Mees, Kerr, 
Rinkel, Algra, & Molyneux, 2011; Scott et al., 2010). Therefore, aneurysm repair method was 
controlled for in specific aim #2 and #3. 
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2.0  BACKGROUND AND SIGNIFICANCE 
Bleeding into the subarachnoid space is a medical emergency that can result from head trauma or 
spontaneous blood vessel rupture. There are several mechanisms that cause spontaneous SAH 
including: intracranial aneurysm, arteriovenous malformation (AVMs), dissection in the cerebral 
vasculature, vasculitides, amyloid angiopathy, or bleeding diatheses (Singer et al., 2011a). Often, 
SAH results when a cerebral aneurysm ruptures and bleeds into the subarachnoid space. Cerebral 
aneurysms are blood-filled pathological focal dilatations of the cerebral blood vessels (Krings et 
al., 2011). The risk factors, pathophysiology, and the complication for the rupture of cerebral 
aneurysms are discussed blow. 
2.1 EPIDEMIOLOGY 
In the United States, an individual experiences a stroke every 40 seconds and dies of a stroke 
every 4 minutes (Roger et al., 2011). Of these strokes, 20% are hemorrhagic (Singer et al., 
2011a). While SAH represents 3-7% of all strokes, it accounts for approximately 25% of 
hemorrhagic strokes (de Rooij et al., 2007; Feigin, Lawes, Bennett, & Anderson, 2003; Lloyd-
Jones et al., 2010; Roger et al., 2011). Although ischemic strokes are more common than 
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hemorrhagic strokes, individuals who experience SAH are twice as likely to die at 1-month post 
injury (32%) compared to those who experience an ischemic stroke (16%) (Feigin et al., 2003).  
Aneurysm rupture is the most common cause for spontaneous SAH; accounting for 85% 
of all non-traumatic cases (Dupont, Wijdicks, Lanzino, & Rabinstein, 2010). Findings from 
prospective autopsy and angiographic studies indicate that 3.6%-6% of the population have a 
cerebral aneurysm (Wardlaw & White, 2000). Fortunately, most cerebral aneurysms do not 
rupture (Singer, Ogilvy, & Rordorf, 2011b; van Gijn, Kerr, & Rinkel, 2007). This is particularly 
true for aneurysms that measure <7mm.  
Among aneurysm types, saccular aneurysms, also known as “berry” aneurysms because 
of their characteristic shape, are the most likely to rupture resulting in SAH (Krings et al., 2011; 
Singer et al., 2011b). The most common location for saccular aneurysms is the arterial junctions 
of the circle of Willis. Approximately, 80-85% of saccular aneurysms are formed in the anterior 
(carotid) circulation and 10% in the posterior circulation. Of anterior circulation aneurysms, 30-
35% occur at the anterior communicating artery, 25-35% at the junctions of the internal carotid 
arteries with the posterior communicating arteries, and 20% at the bifurcation of the middle 
cerebral arteries (Bradač, 2011; Brisman, Soliman, Kader, & Perez, 2010; Schievink, 1997; 
Vega, Kwoon, & Lavine, 2002). Approximately, 10-40% of patients have more than one 
aneurysm and other estimates indicate as many as 75% have two aneurysms. Approximately, 
one-third of patients with multiple aneurysms have mirror aneurysms (bilateral aneurysm on the 
same arterial location); e.g. aneurysm on left and right posterior communicating artery (Bradač, 
2011; Brisman et al., 2010; Brisman, Song, & Newell, 2006; Schievink, 1997).  
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2.2 RISK FACTORS  
Many modifiable and non-modifiable risk factors for aneurysm formation are also risk factor for 
aneurysm rupture (Singer et al., 2011a). Modifiable risk factors include smoking, hypertension, 
alcohol consumption, and sympathomimetic drug use. Race, gender, and genetics are common 
examples of non-modifiable risk factors for aSAH. 
2.2.1 Modifiable risk factors 
Several case control studies report that smoking, hypertension, and alcohol consumption are 
strongly associated with aneurysm formation and rupture (Inagawa, 2010; Qureshi et al., 2001; 
Woo et al., 2009). Current and past smokers have 2-5 times and 1.5 times, respectively, the risk 
of nonsmokers for experiencing an aSAH. Fortunately, the risk decreases shortly after smoking 
cessation (Anderson et al., 2004; V. Feigin et al., 2005; V. L. Feigin et al., 2005). Hypertension 
is potentially the strongest modifiable risk factor for aneurysm formation (Inagawa, 2010). 
Individuals with hypertension have 2-2.5 times the risk of those who are normotensive for 
experiencing an aSAH (V. Feigin et al., 2005; V. L. Feigin et al., 2005). Excessive alcohol 
consumption increases the risk for SAH by 2-4 times compared to those who do not consume 
alcohol (V. L. Feigin et al., 2005; Sankai et al., 1999). The risk for aneurysm formation and 
rupture increases as the number of risk factors increases. For example, individuals who are both 
hypertensive and smoker have 6 times the risk of SAH compared to normotensive non-smokers. 
Further, men who are heavy drinkers and smokers have 6 times the risk of SAH compared to 
non-drinkers and non-smokers. Interestingly, men who have hypertension and are heavy drinkers 
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have 13 times the risk of SAH compared to those who are non-heavy drinkers and normotensive 
or borderline hypertensive. The relative risk of heavy drinkers who are smokers and hypertensive 
is 17.5 (Sankai et al., 1999).  
Sympathomimetic drugs such as cocaine and appetite suppressants are associated with 
aSAH. Notably, subjects with cocaine-associated aSAH are typically younger than the general 
population of aSAH (36 years vs. 52 years respectively). Cocaine use is not only a risk factor for 
aSAH but also an independent risk factor for vasospasm after aSAH (Conway & Tamargo, 
2001). Other sympathomimetic substances used in appetite suppressants, namely 
phenylpropanolamine, have been also associated with increased risk for hemorrhagic stroke 
including intracerebral and subarachnoid hemorrhage (OR =15.9) (Kernan et al., 2000). 
2.2.2 Non-modifiable risk factors  
Racial and gender differences with regard to the incidence of aSAH have frequently been 
reported (Eden et al., 2008; Lindekleiv et al., 2011; Macpherson et al., 2011). For example, 
White Americans have a lower SAH risk and mortality rate compared to other races (Blacks, 
Hispanic, Asians, American Indians, Alaska Natives). Black men have the highest incidence and 
mortality (Bederson et al., 2009; Labovitz et al., 2006). These racial differences are similar to 
those seen in other types of stroke, including those caused by ischemia and intracerebral 
hemorrhage (Cruz-Flores et al., 2011). In addition, several studies have reported that the risk for 
aSAH in women is 1.24 -1.74 times that for men (de Rooij et al., 2007; Eden et al., 2008; 
Lindsay et al., 1983). Studies conducted in Scotland and Sweden have reported that the incidence 
of SAH per 100,000 is 13-14 for women compared to 8-10 in men (Koffijberg et al., 2008; 
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Macpherson et al., 2011). However, studies conducted in Finland reported the opposite with a 
higher incidence in men is compared to women (33 vs. 25 per 100,000 respectively) (Sarti et al., 
1991). Thus, the notion that women have higher risk of SAH than men appears not to be true in 
all countries (Ingall, Asplund, Mahonen, & Bonita, 2000).  
The role of genetics in the pathogenesis of intracranial aneurysms has been strongly 
supported by two observations; first, the familial occurrence of intracranial aneurysms and 
second, the association between heritable connective tissue disease and intracranial aneurysms. 
Polycystic kidney disease and Marfan’s syndrome are two of the most important connective 
tissue diseases that have been associated with intracranial aneurysms (Schievink, 1997). 
Approximately, 5-40% of patients with polycystic kidney disease develop an intracranial 
aneurysm (Yanaka et al., 2004). In fact, autosomal dominant polycystic kidney disease is the 
most common genetic condition associated with intracranial aneurysm formation.  
Several genes were identified as risk factors for intracranial aneurysms. Among those, 
ELN, COL1A2 alleles, eNOS gene T786C polymorphism, and IL-6 gene G572C polymorphism 
are the most promising candidates for this association. It is believed that several genes interact 
with environmental factors to formulate the inheritance pattern in intracranial aneurysms 
(McColgan, Thant, & Sharma, 2010; Ruigrok, Rinkel, & Wijmenga, 2005). Once these factors 
are identified in an individual screening is warranted. Screening is recommended for those who 
have ≥ 2 first degree family members with intracranial aneurysms or genetic conditions 
associated with aneurysm formation such as autosomal dominant polycystic kidney disease and 
Marfan’s syndrome (Brisman et al., 2010).  
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2.3 PATHOPHYSIOLOGY AND HEMODYNAMIC CHANGES 
The pathogenesis of aSAH involves two main processes; aneurysm formation and aneurysm 
rupture which results in bleeding into the subarachnoid space. The exact mechanism of 
intracranial aneurysm formation remains unclear. Prior to discussing the pathogenesis of 
aneurysm formation and rupture, it is essential to describe the vascular anatomy of intracranial 
arteries where aneurysms form. Figure (1) represents a cross sectional view of an intracranial 
artery. Intracranial arteries consist of 4 layers: the adventitia (outermost layer), the media 
(middle muscular layer), the intima (the innermost layer), and internal elastic lamina (separate 
intima from the media) (Bradač, 2011). Compared to extracranial arteries, intracranial arteries 
have thinner adventitia and no external elastic lamina (Stehbens, 1989). Potentially, this 
difference explains why aneurysm formation is more frequent in intracranial arteries compared to 
extracranial arteries (Schievink, 1997). 
 
Figure 1. Cross sectional view of the intracranial arteries 
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For many years, it was believed that risk for aneurysm formation was solely congenital. 
Two major reasons were presented to support this belief: 1) macroscopic examination of the 
aneurysm wall suggested similar appearance as the parent vessel (Stehbens, 1989), and 2) 
histological studies conducted in the early 1930’s found a congenital defect in the media of 
intracranial arteries. Thus, investigators concluded that this defect created a locus minoris 
resistentiae (Latin: an area of low resistance) where aneurysms occurred (Bradač, 2011). Later, 
these findings and interpretations were negated for three reasons. First, on microscopic 
examination the aneurysm wall was found different than the parent vessel (Stehbens, 1989), and 
an absence of the internal elastic lamina and tunica media from the aneurysm wall was observed 
(Bradač, 2011). These findings suggest that the aneurysm wall and the parent vessel wall were, 
in fact, not similar. Second, many normal individuals were found later to have the media defect 
without having an aneurysm (Bradač, 2011). Third, there was no experimental evidence that the 
media defect was a locus minoris resistentiae; that is the area with low resistance where the 
aneurysms form (Stehbens, 1989). 
Series of preclinical experiments to model intracranial aneurysms in sheep, rabbits, rats, 
and monkeys were conducted by Hashimoto et al., in the late 1970’s in Japan and by Stehbens et 
al., in the late 1980’s in New Zealand. These experiments successfully produced aneurysms 
merely by hemodynamic stress even in the absence of connective tissue disease (Hashimoto, 
Handa, & Hazama, 1978, 1979a, 1979b; Hashimoto, Handa, Nagata, & Hazama, 1980; 
Hashimoto et al., 1987; Hassler, 1963; Kim, Kikuchi, Hashimoto, & Hazama, 1989; Stehbens, 
1986, 1989). These experiments confirmed that aneurysms were acquired degenerative lesions 
and not congenital.  Recent studies also corroborated the fact that aneurysm formation is an 
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acquired disorder rather than congenital (Krings, Geibprasert, & terBrugge, 2010; Krings et al., 
2011).  
Despite the experimental evidence that aneurysms can be induced merely by 
hemodynamic stress, others did not find this explanation sufficient. Krings et al., argued that 
explaining aneurysm formation and rupture by hemodynamic stress alone was too narrow 
because it provided the same explanation for aneurysm formation regardless of the underlying 
pathology associated with different aneurysms. Further, this explanation did not consider other 
characteristics that distinguish aneurysms, e.g., different morphological and histopathological 
features. Thus, Krings and colleagues recommended that the pathogenesis of aneurysms should 
be explained by morphologic and histopathologic characteristics in addition to hemodynamic 
stress (Krings et al., 2011). According to Krings et al., aneurysms occur due to luminal forces 
(i.e. increased blood flow/pressure, hemodynamic stress) and abluminal factors (vessel wall 
pathology). Factors that increase the tension inside the blood vessels (luminal factors) and/or 
factors that change the vessels wall (abluminal factors) cause a disruption in the internal elastic 
lamina which leads to outpouching and the subsequent rupture in the intracranial blood vessels 
(Krings et al., 2011). Although the changes in blood pressure that result from hypertension are 
considered luminal forces, others believe that hypertension acts as an accelerator rather than 
being a cause for aneurysm formation (Stehbens, 1989). Yet, the explanation by Krings et. al. is 
notable for explaining causes of aneurysm rupture and formation and  distinguishing or 
/classifying aneurysms that occur due to different disease processes (Krings et al., 2011). The 
classification they suggested for the aneurysms based on their cell wall pathology is presented in 
Table 1.  
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Table 1. Aneurysm types and pathogenesis 
Aneurysm type Pathology 
Saccular (berry) aneurysm  Disruption of internal elastic lamina results from hemodynamic 
factors and/or inflammatory process and leads to focal dilation in 
the arterial wall.  
Mycotic aneurysm Disruption of internal elastic lamina results from bacterial 
invasion for the arterial cell wall. 
Neoplastic aneurysm  Disruption of the arterial wall results from invasion of neoplastic 
cells.   
Immunodeficiency related  Disruption on internal elastic lamina results from inflammatory 
process.  
Segmental ectasia  Smooth muscle atrophy in addition to disruption and degeneration 
of the internal elastic lamina lead to circumferential dilatation of 
the arterial wall.   
Dissecting aneurysm  Disruption of the internal elastic lamina is accompanied with 
blood accumulation through the intima.  
Intramural aneurysm  Characterized by recurrent hemorrhage in the aneurysm wall in 
addition to inflammatory changes in the arterial wall.  
Traumatic aneurysm  Pseudoaneurysm where no actual aneurysm wall is present but 
rather the clotted blood forms the wall of the aneurysm.  
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 Immunohistochemical studies that compared the walls of ruptured and unruptured 
intracranial aneurysms support, in part, the hypothesis made by Krings et al. In these studies 
ruptured aneurysms showed significant endothelial damage, structural wall damage, and 
inflammatory cell invasion compared to unruptured aneurysms. The wall of ruptured aneurysms 
was found weak due to the loss of the smooth muscle cells and destruction of the matrix proteins 
caused by infiltration of macrophages into the vessel wall. These findings suggest that 
inflammation in the vessel wall, which precedes aneurysm rupture and can be considered as 
“abluminal factors”, contributes to the aneurysm formation and rupture (Kataoka et al., 1999).  
Once an aneurysm starts to grow, size becomes important indicator for rupture. 
Hemodynamic stress, blood flow turbulence, and pulsatile flow are the major factors contributing 
to increasing the size of the aneurysm (Wiebers et al., 2004). As the aneurysm grows in size, it 
may eventually rupture and cause aSAH. Aneurysms that rupture have twice the mean diameter 
(8.6 mm) of aneurysms that do not rupture (4.7 mm) (Chason & Hindman, 1958). This suggests 
that larger aneurysms are at a higher risk for rupture compared to smaller aneurysms. The 
increase in the size of an aneurysm can occur over various periods of time. It can take hours to 
years for the aneurysm to grow and eventually rupture. Fortunately, many aneurysms do not 
rupture and many resolve spontaneously (Wiebers et al., 2004).  
2.3.1 Bleeding Into The Subarachnoid Space 
For those aneurysms that rupture, blood moves into the subarachnoid space where cerebrospinal 
fluid (CSF) circulates. Thus, the bleeding often extends to the ventricles. The amount of blood in 
the subarachnoid space and the intraventricular extension are strong predictors of DCI post 
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aSAH (Claassen et al., 2001). The extent of the intracerebral bleeding is usually assessed on 
admission by computed tomography (CT) scan which is a very sensitive tools for identifying and 
localizing blood in the subarachnoid space (Boesiger & Shiber, 2005). Although CT scans are 
not very helpful in diagnosing presence of an aneurysm per se, the pattern of bleeding in can be 
suggestive of aneurysm rupture. A bleeding pattern which predominates in the prepontine 
cisterns with subarachnoid blood in the carotid cisterns, Sylvian fissures, and/or intrahemispheric 
fissure is suggestive of aneurysm rupture (Herrmann & Zabramski, 2007). Evidence suggests 
that the larger the amount of bleeding the higher the risk for complications. Therefore, it is 
important to quantify and assess the amount of bleeding on admission. There are several scales 
used for this purpose. The commonly used scales to assess the severity of the primary injury are: 
Hunt and Hess scale, Fisher grade, modified Fisher grade, Claassesn-Fisher scale, National 
Institute of Health stroke scale (NIHSS), and World Federation of Neurological Surgeons 
(WFNS) grading scale.   
2.3.2 Summary and Critique of Evidence in the Pathophysiology of Aneurysms 
These findings suggest the process of aneurysm formation and rupture is likely to be a complex 
process involving several factors. Although hemodynamic stress was proven in several 
experiments to cause intracranial aneurysms, these experiments do not explain why saccular 
aneurysms are more frequent on arterial bifurcations or why 80-85% of saccular aneurysms 
occur in the anterior circulation. If hemodynamic stress alone were responsible for aneurysm 
formation, the frequency of aneurysms should be similar in different locations of the cerebral 
circulation. These differences suggest that there are anatomical and/or hisological features that 
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make certain locations more susceptible for aneurysm formation or at least for hemodynamic 
changes. One could argue that hemodynamic stress is not the same in all sites of the circle of 
Willis. However, this also suggests that anatomical differences are involved in the pathogenesis 
of aneurysm formation and rupture. The major flaw in the current explanation for aneurysm 
formation and rupture, even that provided by Krings et. al., is that it does not clearly delineate 
factors that contribute solely to aneurysm formation or contribute solely to rupture.  
Regardless the mechanism mechanistic process for aneurysms formation/rupture, 
securing the ruptured aneurysm is am emergency. These patients are typically admitted to the 
neuro-intensive care unit in order to be monitored for secondary injuries such as infarction, 
vasospasm and DCI. These secondary injuries can be more devastating than the primary injury 
(i.e., aneurysm rupture) and they are potentially preventable in many cases.  
2.4 ASSESSING COMPLICATIONS 
After securing the ruptured aneurysm for those who survive the primary insult, monitoring for 
secondary injuries is warranted to prevent further damage to the brain. Secondary injuries after 
aSAH are common and include: hyponatremia, rebleeding, seizure, hydrocephalus, 
cerebrovascular infarction, cerebrovascular vasospasm, impaired cerebral blood flow, and DCI. 
The complications that are related to the current study are discussed below.  
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2.4.1 Cerebral Infarction 
After in-hospital admission, approximately 61% of aSAH survivors develop cerebral infarction. 
Of these infarctions, 40% occur in single cortical areas and 50% occur in multiple areas (Singer 
et al., 2011a). Cerebral infarction is a major predictor of post aSAH outcomes (Juvela & 
Siironen, 2012). It is believed that the relationship between cerebral infarction and functional 
outcomes is causal (Diringer et al., 2011; Vergouwen, Etminan, Ilodigwe, & Macdonald, 2011; 
Vergouwen, Ilodigwe, et al., 2011). Therefore, it was recommended that cerebral infarction 
should be used as an endpoint in aSAH research (Vergouwen, Etminan, et al., 2011). Potentially, 
the effect of infarction on post aSAH outcomes is mediated by DCI. Cerebral infarction has been 
attributed to vasospasm (Carlson & Yonas, 2009), and often used to define DCI (Claassen et al., 
2001). The causal nature of the relationship between vasospasm and infarction has been debated 
(Vergouwen, Etminan, et al., 2011). In the CONSCIOUS-1 trial, successful prevention of 
vasospasm did not significantly reduce infarction rate (Macdonald et al., 2008). This suggests 
that vasospasm is not a sufficient explanation for infarction after aSAH. The mechanics of 
cerebral infarction remain unclear.  
2.4.2 Cerebrovascular Vasospasm 
Post-aSAH vasospasm was first described in 1951 (Ecker & Riemenschneider, 1951) as a 
narrowing in the diameter of cerebral arteries that can be detected by radiographic imaging or 
sonography (Vergouwen, Vermeulen, et al., 2010). If narrowing is significant, it can result in 
decreased blood flow to focal territories of the brain that may eventually result in cerebral 
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ischemia. When vasospasm induced-cerebral ischemia occurs, vasospasm is symptomatic; i.e. 
accompanied with neurologic deterioration such as aphasia, apraxia, and hemiparesis. 
Vasospasm can also be asymptomatic, i.e., not associated neurological deterioration (Frontera et 
al., 2009; Vergouwen, Vermeulen, et al., 2010).  
 Vasospasm has undergone intense exploration in patients post aSAH. However, studies 
have used different methods to measure vasospasm and therefore, different operational 
definitions were given. It is important to discuss these definitions for several reasons. First, 
different measurement methods result in different incidence rates. For example; Frontera et al., 
reported transcranial Doppler (TCD)-vasospasm in 45%, angiographic vasospasm in 31%, and 
symptomatic vasospasm in 16% of 580 subjects (Frontera et al., 2009). Second, it is believed that 
vasospasm contributes to DCI and cerebral infarction; major predictors of poor outcomes. 
Therefore, understanding different definitions of vasospasm is essential for accurate comparison 
of incidence rates and for understanding DCI; a major variable in the current study. These 
definitions include TCD vasospasm, angiographic vasospasm, and symptomatic vasospasm. 
Symptomatic vasospasm is defined as the development of a new focal neurologic deficit (such as 
hemiparesis, aphasia, and apraxia) or global neurologic deficit (deterioration in the level of 
consciousness) that is thought to be caused by arterial narrowing after excluding other causes of 
neurological deteriorations such as hydrocephalus, seizure, and infection (Frontera et al., 2009; 
Vergouwen, Vermeulen, et al., 2010). Angiographic vasospasm is defined as moderate or severe 
arterial narrowing after excluding other possible causes such as atherosclerosis and catheter 
induced vasospasm (Frontera et al., 2009). Cerebral angiography allows to quantify the degree of 
narrowing with >25% defining clinically significant vasospasm, 26-50% defining moderate 
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vasospasm, and >50% defining severe vasospasm (Dankbaar et al., 2009; Yousef et al., 2010). 
Angiographic vasospasm is a very objective measure but angiography is very invasive and 
cannot therefore be routinely used as a method for diagnosing vasospasm due to the risk 
associated with this procedure. TCD vasospasm is defined as: 1) mean arterial velocity >120 
ml/s; 2) systolic arterial velocity >200 ml/s, or 3) Lindegaard ratio >3.0 (for middle cerebral 
artery) (Frontera et al., 2009; Yousef et al., 2010). TCD sensitivity is poor (Carrera, Schmidt, 
Oddo, Fernandez, et al., 2009) and thus may overestimate the incidence of vasospasm. 
Therefore, TCD-vasospasm is of concern when accompanied by evidence of clinical 
deterioration. When no clinical deterioration is present, TCD-vasospasm is usually followed by 
radiologic testing to confirm or rule out vasospasm. 
Vasospasm was once thought to be a major cause for ischemia after aSAH, however, 
evidence shows that even though vasospasm results in a decrease in cerebral blood flow, 
approximately half of patients with severe vasospasm do not develop DCI (Dankbaar et al., 
2009). This indicates that the impairment in cerebral perfusion that results from vasospasm may 
not be sufficient to result in cerebral ischemia in every instance. To test this hypothesis, a 
randomized double blind controlled trial (CONSCIOUS-1 trial) used an endothelin antagonist 
(Clazosentan) to prevent vasospasm. In the CONSCIOUS-1 trial, a significant reduction in 
angiographic vasospasm did not result in significant reduction of DCI or infarction or significant 
improvement in outcomes (Macdonald et al., 2008). A recent systematic review of randomized 
controlled trials similarly reported that effective reduction of vasospasm does not consistently 
result in improvement in outcome (Etminan, Vergouwen, Ilodigwe, & Macdonald, 2011). These 
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findings collectively suggest that role of vasospasm in the pathogenesis of DCI and poor 
outcomes after aSAH is not as strong as was once thought. 
2.4.3 Delayed cerebral ischemia 
The fact that the successful prevention of vasospasm did not improve post-aSAH outcomes 
increased the attention to explore DCI as a primary contributor for poor outcomes after aSAH. In 
their consensus paper, the Neurocritical Care Society defined DCI as a neurological deterioration 
that is thought to be due to ischemic deficit, lasts for > 1 hour, and cannot be attributed to other 
radiographic, electrophysiologic, or laboratory abnormalities (Diringer et al., 2011; Vergouwen, 
Vermeulen, et al., 2010). The term delayed suggests that DCI is not related to initial insults but 
rather to later pathological changes that develop; the secondary injury (Carlson & Yonas, 2009).  
DCI typically occurs 3 -15 days after the initial aSAH, peaking on day 7 and is associated 
with poor outcomes in survivors (Claassen et al., 2001; van Gijn et al., 2007). DCI is common 
after aSAH occurring in 19-63% of patients (Carrera, Schmidt, Oddo, Fernandez, et al., 2009; 
Carrera, Schmidt, Oddo, Ostapkovich, et al., 2009; Claassen et al., 2001; Frontera et al., 2009; 
Hop, Rinkel, Algra, & van Gijn, 1999; Lanterna et al., 2010; Yousef et al., 2010). These 
incidence rates of DCI are underestimated because assessment of neurological deterioration 
requires that the patient be conscious and can undergo neurological examination. Therefore, in 
patients who are comatose or sedated, the presence of DCI cannot be determined (Vergouwen, 
Vermeulen, et al., 2010). Variations in DCI incidence is explained, in part, by the lack of a 
standardized definition used in different studies (van der Bilt et al., 2009). For instance, some 
authors have used vasospasm as one of the criteria to define DCI (Frontera et al., 2009), while 
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others have used infarction (Claassen et al., 2001). The most common definition for DCI used in 
studies published before the Neurocritical care consensus paper is: a clinical deterioration (new 
focal neurologic deficit or decrease in level of consciousness) not attributed to causes other than 
ischemia (rebleeding, seizure, hydrocephalus, hyponatremia, or cerebral edema) and/or cerebral 
infarction/vasospasm (Carrera, Schmidt, Oddo, Fernandez, et al., 2009; Carrera, Schmidt, Oddo, 
Ostapkovich, et al., 2009; Frontera et al., 2009; Vergouwen, van Geloven, et al., 2010; 
Vergouwen, Vermeulen, et al., 2010). The term DCI is often used interchangeably with 
symptomatic vasospasm and delayed ischemic neurologic deficit (DIND) (Al-Tamimi, Orsi, 
Quinn, Homer-Vanniasinkam, & Ross, 2010). However, the term delayed neurologic deficit 
(DND) refers to any neurologic deficit that occurs after initial bleeding, this includes deficits as a 
result of DCI, hydrocephalus, cerebral edema, seizure, electrolyte imbalance, and fever but 
excluding rebleeding (Diringer et al., 2011). 
As mentioned previously, the definition of DCI has two components: impairment in 
cerebral blood flow and neurological deterioration. The decrease in cerebral blood flow leads to 
neuronal cell death and cerebral ischemia that are presented as symptomatic neurologic deficit. 
Cerebral ischemia-associated neuronal cell death can occur as a consequence of two mechanisms 
or processes; apoptosis or necrosis. Apoptosis; defined as programmed cellular death, is 
characterized by cellular shrinkage, chromatin aggregation, intact cellular membrane, and intact 
mitochondrial function (Thompson, 1995). Necrosis is not a regulated process. It results from 
severe cerebral ischemia and is distinguished by mitochondrial injury, cell swelling, lysis in the 
cellular membrane inflammation, and vascular damage. These two processes are not separate; 
rather they coexist on a continuum. The duration and intensity of the ischemic insult determine if 
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the cell is going through apoptosis or necrosis. Severe and longer ischemic insults are associated 
with cell necrosis. It is widely accepted that excitatory amino acids trigger an excitotoxic cascade 
which in turn leads to neuronal necrosis (Harukuni & Bhardwaj, 2006). On the other hand, 
apoptosis results from exposure of neurons with partially functional mitochondria to glutamate 
(Ankarcrona et al., 1995). An intrinsic pathway (mitochondria dependent pathway) and an 
extrinsic pathway (mitochondria independent pathway) are suggested to explain the pathway of 
apoptosis. In the intrinsic pathway, cerebral ischemia leads to disruption of the mitochondrial 
membrane caused by the release of proapoptotic factors. This eventually results in DNA 
fragmentation. In the extrinsic pathway, several death receptors induce and augment cellular 
apoptosis (Harukuni & Bhardwaj, 2006).  
Prevention of neuronal death that results in DCI has been the focus of treatment for 
decades. Despite multiple treatment options, DCI, regardless of how defined, remains a primary 
cause of morbidity and poor outcomes after aSAH (Frontera et al., 2009; Laskowitz & Kolls, 
2010; Rabinstein et al., 2005; Schutz et al., 1993; van Gijn et al., 2007). DCI is associated with 
severe disability, poorer performance of activities of daily living, increased cognitive 
impairment, reduced quality of life, and death (Frontera et al., 2009; Rabinstein et al., 2005; 
Schutz et al., 1993). On the other hand, there are several factors associated with DCI such as low 
cerebrovascular reactivity on day 4-7 and 8-10 after ictus (Carrera et al., 2010), loss of 
consciousness > 1 hour after the onset of aSAH (Hop et al., 1999), C-reactive protein, leukocyte 
and platelet count (Kasius, Frijns, Algra, & Rinkel, 2010), cisternal and intraventricular blood 
(Claassen et al., 2001; Ko et al., 2011), and thromboembolism (Stein, Levine, Nagpal, & 
LeRoux, 2006). Yet, treatment options that target these factors did not result in improvement in 
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post-aSAH outcomes. Vasospasm was thought to be strongly associated with DCI but recent 
evidence suggests that vasospasm does not always lead to DCI (Dankbaar et al., 2009). Thus the 
prevention of focal perfusion deficit is not a successful strategy to prevent DCI and improve 
outcomes post aSAH.  
While the definition of DCI-related clinical deterioration includes evidence of focal and 
global (level of consciousness) neurologic deterioration, the cause for this deterioration is usually 
attributed to focal (regional) impairment in blood flow (i.e. cerebrovascular infarction and 
vasospasm) (Laskowitz & Kolls, 2010; Rabinstein et al., 2005; Stein, Browne, Chen, Smith, & 
Graham, 2006; Stein, Levine, et al., 2006). Treatment of focal (regional) cerebral hypoperfusion 
does not prevent DCI or significantly improve outcomes (Dorhout Mees et al., 2007, 2008; 
Macdonald et al., 2008; van den Bergh et al., 2006). Therefore, exploring global cerebral blood 
flow as a contributor to DCI and poor outcomes post aSAH is warranted. 
2.4.4  Cerebral perfusion pressure, cerebral blood flow, and cerebral autoregulation 
The brain is totally dependent on continuous and relatively constant blood flow; it consumes 
15% of total cardiac output, 20% of total oxygen, and 25% of total glucose utilized by the whole 
body. Because neurons do not store glucose, the brain is not capable of tolerating the absence of 
blood flow for periods as short as 10 seconds. In such situations, neurons can become 
nonfunctional but remain alive for approximately 30 minutes. Conversely, when cerebral blood 
flow is impaired, neurons can remain alive for up to 6-8 hours (Roach, Bettermann, & Biller, 
2010). Normal cerebral blood flow in an awaking adult is approximately 50ml/100g/min. The 
threshold for ischemia is 18ml/100g/min while the threshold for irreversible damage is 
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1ml/100g/min (Dagal & Lam, 2011). At the latter threshold, cells are permanently dead and 
brain damage is irreversible. When cerebral blood flow is impaired in certain territories (e.g. due 
to focal infarction or vasospasm), the collateral circulation is recruited to keep the tissue 
potentially recoverable (ischemic penumbra). In global ischemia (e.g. inadequate cerebral 
perfusion pressure), the blood flow in the collateral circulation is also impaired which limits the 
ability to recover brain tissue (Roach et al., 2010). Therefore, global cerebral perfusion deficit 
can be more devastating than focal perfusion deficit. A process called “cerebral autoregulation”, 
which is often impaired in aSAH patients, normally regulates global cerebral perfusion.  
Cerebral autoregulation refers to the ability of the brain to maintain a relatively constant 
blood flow in spite of changes in MAP and CPP (Paulson, Strandgaard, & Edvinsson, 1990). 
Typically, cerebral autoregulation functions within a MAP window of 60-150 mmHg or a CPP 
window of 50-100 mmHg (Paulson et al., 1990; Smith & Amin-Hanjani, 2011). This window is 
not fixed and depends on several factors such as carbon dioxide levels, sympathetic activity, and 
certain disease states. For example patients with chronic hypertension have higher thresholds 
compared to normotensive patients (Paulson et al., 1990; Strandgaard & Paulson, 1989). The 
cerebral vasculature reacts (dilate/constrict) according to changes in blood pressure to keep 
cerebral blood flow relatively constant. When CPP falls below the lower limit in intact 
autoregulation function, arteries and arterioles start to constrict to maintain the perfusion 
pressure (Gabrielli, Layon, & Yu, 2008). Impairment of cerebral autoregulation after aSAH has 
been noticed previously and can be predictive of poor outcomes (Hattingen et al., 2008; Lang, 
Diehl, & Mehdorn, 2001). Impaired autoregulatory function causes cerebral blood flow to be 
exclusively dependent on blood pressure thus small changes in blood pressure or cerebral 
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perfusion pressure can alter cerebral perfusion dramatically. Low CPP (<60 mmHg) can impair 
autoregulation, while increasing CPP in the absence of intact autoregulatory function (cerebral 
vessels are non-reactive) can lead to reperfusion hyperemia. Subsequently, this leads to increase 
in ICP, decrease in CPP, and finally reduced cerebral blood flow. This mechanism has been 
implicated in the pathogenesis of secondary brain injury (Czosnyka & Pickard, 2004; Dagal & 
Lam, 2011) and can be potentially employed in post-aSAH secondary insults such as DCI.  
Normally, cerebral autoregulation maintains a relatively constant blood flow to the brain 
in spite of changes in CPP/MAP (Aaslid, Lindegaard, Sorteberg, & Nornes, 1989). Impairment 
of cerebral autoregulation after aSAH is associated with low CPP (Jaeger, Schuhmann, Soehle, 
Nagel, & Meixensberger, 2007; Lang et al., 2001). Elevated CPP values can also cause 
impairment in autoregulation (Czosnyka, Brady, Reinhard, Smielewski, & Steiner, 2009). When 
cerebral autoregulation is impaired, even small changes in CPP may not be tolerated by the 
brain; leading to cerebral hypoxia. In patients with head injury, CPP augmentation results in 
increased brain tissue oxygenation (Johnston et al., 2005). Increased cerebral tissue oxygenation 
improves outcomes after aSAH (Al-Rawi et al., 2010).  
These findings suggest a role for CPP in the pathogenesis of cerebral ischemia and poor 
outcomes after aSAH.  CPP is the pressure gradient between mean arterial pressure (MAP) and 
intracranial pressure (ICP) that allows blood to flow to the brain (Alvarez del Castillo, 2001). 
Changes in ICP, MAP, and CPP are common after aSAH. Approximately, ¾ of aSAH patients 
experience abnormal fluctuations in ICP, MAP, and CPP (Ryttlefors et al., 2007). These 
fluctuations result in decreases in cerebral blood flow; but it is unknown whether CPP changes 
are associated with DCI and poor outcomes post aSAH. Several studies have suggested that CPP 
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may serve as a clinically informative index of global cerebral perfusion deficit associated with 
DCI and poor outcomes (Cahill et al., 2006; A. P. Huang et al., 2010). Continuous cerebral blood 
flow monitoring at the bedside is not possible and patient transport to the radiology department 
for imaging can result in serious adverse events (Swanson et al., 2010), thus CPP may be a good 
indicator for continuous assessment of adequate cerebral blood flow. Schmidt and colleagues 
have recruited 30 subjects to study the relationship between CPP, brain tissue hypoxia, and 
metabolic crisis. They found that a CPP ≤ 70 mmHg was associated with metabolic crisis (OR 
2.1) and brain tissue hypoxia (OR 2.0). In addition, brain tissue hypoxia and metabolic crisis 
were significantly associated with poor functional outcomes at 3 months following aSAH but not 
with mortality (Schmidt et al., 2011). However, this study did not investigate DCI per se and it 
was unclear if patients with brain tissue hypoxia were symptomatic. Further, this study did not 
examine that relationship between CPP and poor functional outcomes or poor 
neuropsychological outcomes, a frequently missed outcome measure. 
2.5 OUTCOMES 
During hospital stay post aSAH admission, patients are monitored for the complications 
discussed above in order to maintain stable hemodynamics as well as to prevent poor outcomes 
and death. After discharge, the physical and the cognitive functional levels are crucial for 
survivors. Up to 63% of aSAH survivors suffer long-term functional disabilities and up to 42% 
suffer cognitive disabilities (Mayer et al., 2002; van der Bilt et al., 2009). These disabilities 
include: inability to carry out activities of daily living, resume pre-injury activities and to return 
  
 
32 
to work (Al-Khindi, Macdonald, & Schweizer, 2010). DCI, cerebral infarction, and initial 
neurological status are the strongest predictors of poor outcomes after aSAH (Diringer et al., 
2011; Frontera et al., 2009; Macdonald, Pluta, & Zhang, 2007; Springer et al., 2009; Vergouwen, 
Ilodigwe, et al., 2011). Despite that fact that these predictors are known, only nimodipine, a 
calcium channel blocker, has been proven in prospective randomized controlled trials to improve 
outcomes (Diringer et al., 2011). In spite of the different treatment options, outcomes after aSAH 
remain poor. This is becoming more prevalent as mortality decreases after aSAH; therefore more 
individuals are left with poor physical and neuropsychological functions. 
Post aSAH outcomes are often measured through functional and neuropsychological 
assessments; however, functional assessments are more commonly measured (Diringer et al., 
2011; Macdonald et al., 2007; Vergouwen, Ilodigwe, et al., 2011). The majority of studies that 
have investigated the effect of ICP, MAP and DCI on outcomes relied mainly on disability 
assessments (e.g., Glasgow outcome scale or modified Rankin scale) as primary endpoints 
(Beseoglu, Unfrau, Steiger, & Hanggi, 2010; Cormio et al., 2001; Jaeger et al., 2007; Kirkness, 
Burr, & Mitchell, 2009). While this approach evaluates the impact on functional outcomes, it 
does not evaluate neuropsychological impairment; an important source of disability and 
neurologic deficit in these patients (Saciri & Kos, 2002).  
Functional outcomes are often classified as severe versus moderate disability or poor 
versus good. Assessment is usually made at 3, 6 and/or 12 months after bleeding. Severe 
disability occurs in 61% of patients at discharge and 21% at 3 months, while moderate disability 
occurs in 21% of patients at discharge, and 40% at 3 months (Beseoglu et al., 2010; Naidech et 
al., 2005). Poor functional outcomes occur in 20-40% of patients at 6 months, and in 34% after 1 
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year (Langham et al., 2009; Ohwaki et al., 2006; Soehle et al., 2007). Overall poor functional 
outcomes occur in 16%-63% of patients with aSAH (van der Bilt et al., 2009). Interestingly, 
variability in arterial blood pressure is related to 6 month functional outcomes (measured by 
GOS) with a greater and faster 5-second variability associated with better outcomes and greater 
24-hour variability associated with worse functional outcomes (Kirkness et al., 2009). These 
findings suggest that factors that affect global cerebral perfusion are related to functional 
outcomes post aSAH. Predictors of poor functional outcomes include: DCI (Frontera et al., 
2009), larger baseline intraventricular hemorrhage (A. H. Kramer et al., 2010), cardiac 
dysfunction (van der Bilt et al., 2009), cardiac arrhythmias (Frontera et al., 2008), age, 
hydrocephalus (Ohwaki et al., 2006), fever, anemia, hyperglycemia (Wartenberg et al., 2006), 
amount of initial bleeding, initial neurologic condition (Hijdra, van Gijn, Nagelkerke, 
Vermeulen, & van Crevel, 1988), elevated ICP (Karnchanapandh, 2008), and rebleeding (Hijdra, 
Braakman, van Gijn, Vermeulen, & van Crevel, 1987).  
Poor neuropsychological outcomes are common post aSAH. Approximately, 21%-76% 
of patients have cognitive impairment post aSAH (Al-Khindi et al., 2010; Mayer et al., 2002; 
Springer et al., 2009). Mayer et al., recruited 113 patients with SAH to evaluate the impact of 
cognitive impairment on functional outcomes and quality of life after SAH. Three-month 
neuropsychological assessment was performed in 7 domains: verbal memory, visual memory, 
motor functioning, reaction time, executive function, visuospatial functioning, and language 
functioning. The highest proportion of impairment was found in the verbal memory domain 
(42%) and the lowest percentage of impairment was found in the executive function domain 
(18%). After the adjustment for age, race, and education, none of the seven domains were 
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associated with global handicap measure (assessed by modified Rankin scale) (Mayer et al., 
2002). Findings from a recent systematic review to determine the impact of aSAH on 
neuropsychological function and functional outcomes indicate that the most common areas of 
cognitive impairment in aSAH patients are: memory, executive function, and language. Others 
report that cognitive impairment negatively impacts the activity of daily living, ability to return 
to work, and quality of life (Al-Khindi et al., 2010). Variables that are associated with 
neuropsychological impairment include: DCI, symptomatic vasospasm (Frontera et al., 2009; 
Springer et al., 2009), global cerebral edema, left sided infarction (Kreiter et al., 2002), fever, 
anemia with blood transfusion, and cerebrospinal fluid 20-HETE (Crago et al., 2011). 
In summary, development of DCI has been associated with poor functional and 
neuropsychological outcomes after aSAH (Al-Tamimi et al., 2010; Frontera et al., 2009; Schutz 
et al., 1993; Springer et al., 2009) but no monitoring approach has been shown to be effective in 
guiding medical management to prevent these sequelae. Continuous monitoring of cerebral blood 
flow and the bedside is critical but not possible. CPP can be used as an indicator of cerebral 
blood flow.  
2.6 SIGNIFICANCE AND INNOVATION 
Diagnosis of DCI is often late and occurs after the patient develops symptoms. Moreover, 
medical centers do not often perform serial radiographic testing to assess cerebral blood flow 
(Frontera et al., 2009), thus finding indicators for cerebral blood flow can be used as a screen-in 
tools to determine patients who need further investigation. These tools can potentially maximize 
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the use of hospital resources, reduce cost, and enable early detection of complications. 
Monitoring cerebral blood flow continuously at the bedside is not possible. However, CPP can 
be indicative of cerebral blood flow and thus used as a tool for determining patients who may 
need further investigation. Therefore, findings from the current study are expected to improve 
methods for monitoring complications and poor outcomes after aSAH. The outcome 
measurement in the current study is unique in using multidimensional longitudinal assessment 
including functional and neuropsychological evaluation at 3 and 12 months post aSAH. Our 
hypothesis is novel in proposing global cerebral perfusion deficit (i.e. low CPP) as a risk factor 
for DCI post aSAH as well as proposing DCI as a mediator for poor outcomes in patients with 
aSAH. 
It is important to emphasize that the question in this study is not whether low CPP results 
in cerebral ischemia (this is already known). Rather, this study addresses the question of whether 
DCI that is thought to happen due to local vascular alteration (vasospasm/infarction) is related to 
global cerebral perfusion deficit (i.e. CPP). Understanding this question is important to utilize the 
findings optimally and to assess the innovation of this study. There are several other unique 
aspects in this study: 
1. The literature supports a relationship between MAP, ICP, DCI, and poor functional 
outcomes (Frontera et al., 2009; Kirkness et al., 2009; Soehle et al., 2007). Despite these 
known relationships, the relationship between CPP and DCI has not been evaluated in 
prior studies. The current study evaluated the relationship between CPP, DCI, and post 
aSAH outcomes.  
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2. CPP is a relatively simple and low-cost monitoring tool. It is a single parameter that can 
be used as a surrogate measure of cerebral blood flow. This is particularly important 
because continuous bedside assessment of cerebral blood flow is not possible. Patients 
must be transported to the radiology department to obtain this assessment, which has 
known risks in unstable patients.  
3. Changes in CPP impact global cerebral perfusion (overall cerebral blood flow).  Blood 
flow in collateral circulation is also impaired in global cerebral hypoperfusion. Therefore, 
the ability of collateral cerebral blood flow to compensate is limited compared to the case 
focal perfusion deficit (insufficient blood flow in certain cerebral territories). Improving 
focal cerebral blood flow does not significantly improve outcomes or prevent DCI. Our 
hypothesis represents an innovative approach to explaining the pathogenesis of DCI and 
poor outcomes. 
4. The majority of studies that have investigated the effect of ICP, MAP and DCI on 
outcomes have used gross functional outcome measures (Glasgow outcome scale, 
modified Rankin scale) as indicators of function (Beseoglu et al., 2010; Cormio et al., 
2001; Jaeger et al., 2007; Kirkness et al., 2009). Such measures are inadequate to identify 
specific areas to target for interventions to compensate for neuropsychological 
dysfunction. The current study has used more comprehensive measures of both functional 
and neuropsychological outcomes to provide data to guide future interventions.  
5. This is the first study to investigate the relationships between Hunt and Hess grade, CPP, 
DCI, and neuropsychological outcomes after aSAH and to test whether DCI mediates the 
relationship between Hunt and Hess grade and poor outcomes. Understanding these 
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relationships will potentially aid clinicians and administrators to develop clinical 
guidelines to minimize complications.  
2.7 IMPLICATIONS TO PRACTICE 
Monitoring is an essential task for nurses in intensive care settings. Monitoring cerebral blood 
flow is a key task for preventing such complications after aSAH. Nursing is being tasked with 
frequent monitoring but limited in scope. Therefore, it only alerts the nurses to a symptom, not 
the underlying cause. Monitoring of CPP as a marker DCI is beyond monitoring symptoms; it 
involves monitoring risk factors and thus opens new areas for nursing research and interventions 
for controlling CPP that will potentially prevent DCI and improve patients’ lives.  
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3.0  METHODS 
3.1 DESIGN 
This is a descriptive longitudinal study that investigated the relationship between CPP, DCI, 
severity of bleeding and poor outcomes post aSAH. Data sources included medical records and 
charts from a parent study. The parent study is an ongoing NIH funded study (R01 NR004339-
10, Dr. Samuel Poloyac and Dr. Paula Sherwood, Co- PIs), which recruits patients with aSAH to 
examine the physiologic predictors of complications and outcomes post aSAH. The study is 
conducted at the University of Pittsburgh - School of Nursing, School Pharmaceutical Sciences, 
and University of Pittsburgh Medical Center (UPMC).  
3.2 SETTING 
The data collection site for the parent study is a 20-bed neurovascular intensive care unit (NICU) 
at the UPMC-Presbyterian Hospital. Fourteen percent of admissions to the NICU are patients 
with aSAH. UPMC-Presbyterian, an adult medical-surgical referral hospital and site of ongoing 
research located in southwest Pennsylvania, is a Level I Regional Resource Trauma Center with 
well-established neurology and neurosurgery departments. The Department of Neurological 
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Surgery is nationally and internationally recognized for innovative research and high-quality 
training programs. UPMC has a state of the art Comprehensive Cerebrovascular Neurosurgery 
Center that includes the Center for Endovascular Therapy that provides care for patients with 
intracranial aneurysms. The Cerebrovascular Neurosurgery Center collaborates with the UPMC 
Stroke Institute and has a specialized multidisciplinary team that is available 24 hours a day, 7 
days a week and includes neurologists, neurosurgeons, radiologists, neurointensivists, 
physiotherapists, speech therapists, social workers, and nurses.    
3.3 SAMPLE 
The sample included monitored patients 21-75 years of age with aSAH admitted to UPMC 
Presbyterian NICU between May 1999 and October 2011, and enrolled in the parent study. On 
average, the research team recruits 40-50 subjects each year, approximately 75-85% of whom 
have an external ventricular drain (EVD) placed for ICP monitoring and cerebrospinal fluid 
drainage. Those subjects either have an arterial line for continuous blood pressure monitoring or 
a blood pressure cuff for noninvasive intermittent blood pressure monitoring every two hours. 
The sample was inclusive of the general population; there was no restrictions based on gender, 
race, or socioeconomic status. 
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3.3.1 Inclusion and exclusion criteria 
Inclusion criteria for this analysis were: 1) new diagnosis (within 5 days) of spontaneous SAH 
due to aneurysm rupture (verified via computed tomography [CT] scan and cerebral 
angiography), 2) Hunt and Hess grade of ≥3 and/or Fisher grade ≥ 2, 3) admitted to the NICU, 4) 
blood pressure and intracranial pressure measurements available, 5) 21-75 years of age, and 6) 
able to read/speak English. Exclusion criteria were: 1) preexisting chronic neurologic disease, 2) 
traumatic SAH, or 3) traumatic aneurysm rupture or mycotic aneurysm.  
3.3.2 Sample size estimates for the current study 
Using PASS 11, Optimal Design software, and sample size tables; the results of power analyses 
to calculate sample size for the current study were as follow: 
• Specific Aim #1a: This aim is exploratory descriptive in nature and does not require 
sample size calculation.  
• Specific Aim #1b: Growth curve power analysis revealed that 205 subjects are needed to 
achieve 80% power at a level of significance of 0.05 to detect effect size as small as 0.4. 
• Specific Aim #2a: Logistic regression power analysis for DCI as a function of CPP 
revealed that 210 subjects are needed to achieve 80% power to detect odds ratio as small 
as 1.47 at a level of significance of 0.05. 
• Specific Aim #2b: ROC curve power analysis revealed that a sample of 68 from the 
DCI(-) group and 91 from the DCI(+) group will achieve 80% power to detect a 
difference of 0.1 between the area under the ROC curve (AUC) under the null 
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hypothesis of 0.80 and an AUC under the alternative hypothesis of 0.90 using a two-
sided z-test at a significance level of 0.05. Total number of subject need is 159. 
• Specific aim #2c: power analysis revealed that 202 subjects are needed to achieve 80% 
power at a 0.05 significance level to detect regression coefficient equal to 0.3. 
• Specific aim #3: utilizing sample size estimate table for mediation analysis proposed by 
Fritz and MacKinnon (2007), we found that analyzing this aim using biased corrected 
bootstrapping requires 148 subjects to achieve 80% power and detect an effect size as 
small as 0.26 at a level of significance of 0.05 (Preacher & Hayes, 2004). 
By comparing all sample size estimations, the largest sample size needed is 210. In the parent 
study, we have data available for an estimated sample size of 211 subjects. Thus, all 211 subjects 
were included in this analysis.  
3.4 RECRUITMENT 
Subjects are recruited within 5 days of the onset of the hemorrhage and data are collected from 
the time of consent through 14 days after aSAH or until discharge. Approximately 85% of 
eligible subjects are enrolled in the parent study. After screening patients newly admitted to the 
NICU and determining their eligibility status, a comprehensive explanation for the study 
including the purpose, risks, benefits, and data collection procedures was provided. All patients 
who agreed to enroll and be part of the study, were asked to sign the consent. Subjects were also 
informed that the participation is completely voluntary and their decision to enroll in the study 
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will not affect their standards of care. Further, subjects were informed that they can withdraw 
from the study at any time.  
3.5 DATA COLLECTION 
To extract medical record data, the PI (KY) has collaborated with the Center for Assistance in 
Research using eRecords (CARe) at the University of Pittsburgh to obtain study variables. The 
parent study does not collect CPP values prospectively, thus CARe programmers has retrieved 
the requested data. The data collection procedure in the parent study that is related to this 
analysis included: 1) Screen all subjects admitted to the NICUs, 2) Determine eligibility, 3) 
Consent eligible subjects, 4) Collect baseline data, 5) TCD to assess cerebral blood flow 
velocities, 6) Review angiography and CT scan reports that are ordered by the medical team, 7) 
Follow up for in-hospital clinical deterioration, and 8) Disability and neuropsychological 
assessment at 3 and 12 months (post bleeding), through phone calls and home visits.  
  
 
43 
3.6 TIMETABLE FOR THE STUDY 
Table 2. Timetable of the study 
Study activities  Year 1 Year 2 
 Q1 Q2 Q3 Q4 Q1 Q2 Q3 
Meet with the Co-Is X X X X X X X 
Data collection  X X     
Data entry and merging relevant datasets  X X     
Data cleaning and analysis   X X    
First Manuscript preparation    X X   
Second Manuscript preparation     X X  
Dissertation manuscript preparation      X X 
Dissertation defense        X 
Sending manuscripts to relevant journals       X X 
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3.7 STUDY VARIABLES 
3.7.1 Delayed cerebral ischemia (DCI) 
DCI was defined as the presence of clinical deterioration, not attributable to rebleeding, seizures, 
hydrocephalus, and cerebral edema, accompanied by evidence of abnormal cerebral blood flow 
(Yousef et al., 2010). Subjects were classified as DCI-present if they had both clinical 
deterioration and one or more indicators of abnormal cerebral blood flow, and DCI-absent if they 
had no evidence of clinical deterioration or no evidence of abnormal cerebral blood flow on any 
of the below diagnostic modalities. Subjects with a DCI status that could not be determined 
according to the above definition were excluded from this analysis (e.g., subjects who are 
comatose or sedated and thus their neurologic decline cannot be evaluated).  The variable “Time 
to DCI” was defined as the number of hours from aneurysm rupture to the time of DCI diagnosis 
and was analyzed as ratio dependent variable 
 Indications of clinical deterioration included: a) decrease in level of consciousness 
measured by Glasgow coma scale, b) presence of a new focal neurologic deficit, c) deterioration 
in pupillary reaction, or d) worsening score on the National Institute of Health Stroke Scale 
(NIHSS). Cerebral blood flow assessments within 12 hours (before, after, or both) of the 
observed neurologic deterioration were evaluated. Cerebral blood flow was assessed by any of 
the following methods: 
1)  Transcranial Doppler (TCD) assessments performed daily, indications of abnormal 
blood flow included a) mean middle cerebral artery velocity >120 ml/second; b) 
systolic middle cerebral artery velocity >200 ml/second or c) Lindegaard ratio >3.0.  
  
 
45 
2)  Head CT and CT perfusion scans, which provide accurate and reliable measurement 
of cerebral blood flow (Wintermark, Thiran, Maeder, Schnyder, & Meuli, 2001), 
within the 12-hour temporal window of the clinical deterioration, were reviewed for 
the presence of cerebral ischemia, infarction or abnormal blood flow.  
3)  Cerebral angiography studies within the same temporal window were independently 
reviewed and evaluated by a neurosurgeon for vascular narrowing, with narrowing > 
25% considered as indication for cerebral vasospasm.  
 
3.7.2 Cerebral perfusion pressure (CPP) 
CPP was defined as the difference between mean MAP and ICP and measured in mmHg. In the 
parent study, MAP was measured either invasively using an arterial line or noninvasively using a 
blood pressure cuff. ICP was measured invasively by an external ventricular drain (EVD). CPP 
was measured at least every two hours. However, subjects who exhibited neurologic or systemic 
instability had more nursing surveillance and thus more CPP values. Typically, data collection 
lasted for 14 days after the bleeding onset unless a subject was admitted more than one day after 
bleeding onset or subject was discharged before the 14-day period. In either case, CPP values 
were available for <14 days. Due to the nature of ICP and CPP measurement in these subjects, 
CPP values were intermittent rather than continuous. While continuous CPP and ICP monitoring 
is more likely to capture all abnormal values, it was not possible in our subjects as ICP was 
measured by EVD, which needed to be clamped intermittently to obtain valid ICP. Further, the 
EVD in these subjects was open most of their time for CSF drainage, while the ICP was 
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measured only when the EVD was clamped. Therefore, the ICP measurement via the EVD might 
not represent the precise ICP values that the subject had most of the day while the EVD was 
open. In Specific Aim #1, CPP values were used as follows: 
• Absolute CPP values (CPPall): all CPP values measured for patients overtime.   
• Baseline CPP (CPPbase): the first CPP value obtained in the first 24 hours after admission.  
• Maximum CPP (CPPmax): the daily highest value of the measured CPP. 
• Minimum CPP (CPPmin): the daily lowest value of the measured CPP. 
• Mean of CPP (CPPmean): the daily average of CPP values.   
• Standard deviation of CPP (CPPSD): daily standard deviation of CPP values.   
• Percentage of CPP values less than or equal 70 (%CPP<70). 
• Percentage of CPP values more than or equal 100 (%CPP>100). 
The above CPP measurements were used only in Aim 1a to describe CPP changes over time after 
aSAH. In Aim 1b, all CPP values measured during the 14 days post bleeding were used to test 
the significance of CPP changes overtime. In Specific Aims 2, the minimum CPP values 
measured 12 hours prior to time of DCI diagnosis were used.   
3.7.3 Patient outcomes 
Post-discharge outcome interviews that include functional and neuropsychological assessment 
for the parent study were conducted in the neurosurgery clinic or in the subject’s home by 
personnel trained in conducting outcome evaluation. These interviews were conducted without 
distractions or interruptions.  
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I) Neuropsychological outcomes were determined using a comprehensive battery of 
neurocognitive tests at 3 and 12 months following aSAH. Seven cognitive domains were 
assessed: attention, learning and memory, psychomotor speed, mental flexibility, executive 
function, visuo-spatial ability, and language. The selected tests have detailed scoring 
methods, excellent psychometric properties (Franzen, 1989; Mitrushina, Boone, & D'Elia, 
1999)  and have been demonstrated to be sensitive to changes in cognitive function or to 
cognitive impairment in large clinical trials studying the effects of neurological conditions on 
long-term neuropsychological outcomes (Butters et al., 1990; Hachinski et al., 2006). To 
minimize practice effects, alternate versions of tests were used at follow up testing when 
possible. 
• Attention:  was assessed by the Trail Making Test (Part A) which required the subject to 
draw a line connecting circled numbers in numerical sequence as quickly and accurately 
as possible. The test is highly sensitive to neurological impairment and has been used to 
detect cognitive impairment in multiple populations (Moertel, Reitemeier, Bolton, & 
Shorter, 1964; R. Reitan, 1958; Wieneke & Dienst, 1995). The test was scored by the 
number of seconds needed to complete the task; higher numbers indicated poor function.  
• Learning and Memory: Three tests were administered within this domain.  
o Digit Span Forward and Backward measured immediate verbal memory and 
required the subject to listen to series of digits and orally repeat them in the order 
given (forward) and in reverse order (backward). The test was scored by the total 
number of digit sequences subjects were able to correctly recall as well as the 
longest number of digits in each sequence they were able to recall. Lower scores 
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indicated poor function. Validity has been established in studies of subjects with 
aSAH (Ogden, Mee, & Henning, 1993).  
o Logical Memory, a well-known subtest from the Wechsler Memory Scale, 
assessed short and long term verbal memory and required the subject to recall a 
meaningful story (Morris, Kunka, & Rossini, 1997). Two meaningful stories (A 
and B) were read to the patients. Story A was told once to the subject who was 
asked to immediately recall the story to the examiner (short term recall) and then 
recall it again 30 minutes later (delayed recall). Story B was told twice to the 
subject who was asked to recall the story after each telling (short term recall) and 
after a 30-minute delay (delayed recall). The score was the total number of items 
that the subject was able to recall from each of the stories immediately after they 
were read as well as when they were recalled 30 minutes later. Lower scores 
indicated poor function. This test has been effective in differentiating between 
demented and non-demented individuals (Johnson, Storandt, & Balota, 2003).  
o The Rey Complex Figure Test is a nonverbal memory task that requires subjects 
to copy a complex geometric design, and then draw it from memory both 
immediately and 30 minutes later (Meyers & Meyers, 1995). This test was scored 
by the number of elements in the figure the subject was able to correctly recall as 
well as how accurately they were placed while drawing it from memory. The 
score ranges between zero and 36; lower scores indicate poor function. Validity 
has been established in subjects with brain injury (Hinchliffe, Murdoch, & 
Chenery, 1998). 
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• Psychomotor Speed: The Grooved Pegboard was used as a measure of finger dexterity, 
eye-hand coordination (i.e., psychomotor integration), and motor speed (Rourke, Yanni, 
MacDonald, & Young, 1973). The subjects were asked to put notched pegs into a board 
that has 25, irregularly positioned holes as fast as possible. The test was performed using 
both the dominant and non-dominant hand. The subjects were instructed to put the pegs 
in order; left to right for the right hand and right to left for the left hand. This test was 
scored by the number of seconds needed to complete the task. Higher scores indicate 
poor function. The test is sensitive to hemispheric disability (Matthews, Cleeland, & 
Hopper, 1970). 
• Mental Flexibility: The Trail Making Test B is a well-known test of mental flexibility and 
visuomotor tracking (R. M. Reitan & Wolfson, 2004). In this test, the subjects were asked 
to connect circles that have letters (A-L) and numbers (1-13) in an ascending order 
alternating between numbers and letter (e.g. 1-A-2-B-3-C…). This test was scored by the 
number of seconds needed to complete the task and higher numbers indicate poor 
function. Validity information is described above with the Trail Making Test A.  
• Executive Function: The Stroop Color Word Test measures how accurately and quickly a 
person can shift perceptual set and choose an unusual response in place of a habitual 
response. This test required the subject to firstly read the name of color typed in black ink 
as quickly as possible. Secondly, x’s were printed out in red, green and blue and the 
subjects were required to name the ink color. Thirdly, the subject was required to name, 
as quickly and accurately as possible, the ink color that was incompatibly typed with a 
different color name (e.g., BLUE, GREEN, RED). The test was scored by the number of 
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items completed in 45 seconds. Lower scores indicate poor function. The Golden version 
was used in the parent study (Golden, 1978).  
• Visuospatial Ability: Visuospatial ability was assessed with the ‘copy’ component of the 
Rey Complex Figure Test described above.  
• Language:   
o The Controlled Word Association test assesses the ability of subjects to 
spontaneously generate a list of words beginning with designated letters (F, A, S) 
of the alphabet in one minute (Lezak, 1995). Subjects were given 60 seconds for 
each letter.  
o The Animal Naming test requires subjects to say as many animal names as 
possible within one minute.  
The total number of words correctly generated in 60 seconds scored these tests. 
Validity for both tests has been well established in subjects with a variety of 
neurologic insults (Binetti et al., 1995; Shoqeirat, Mayes, MacDonald, Meudell, & 
Pickering, 1990). 
Patients were classified as either having a neuropsychological impairment or not having a 
neuropsychological impairment. This classification may have resulted in loss of information as a 
consequence of summarizing the individual tests into one variable. To compensate for this loss 
of information, descriptive statistics (means and standard deviations) for each test in each 
domain are provided in the results section of this analysis. There are several approaches for 
classifying cognitive function (Shilling, Jenkins, & Trapala, 2006). One approach/method used 
by Wefel and colleagues (2004) was adopted in this study. In this method all test scores in all 
domains were standardized and converted to z scores. Patients with a z score of ≤ -1.5 in more 
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than one test or patients with z score ≤ -2.0 in at least one test were considered to have 
neuropsychological impairment (Wefel et al., 2004). One advantage of this method is that it uses 
all tests scores rather than using domain scores or factor analysis to determine 
neuropsychological impairment, both of which minimize the number of tests utilized in the 
analysis. Using all test scores minimizes information loss that results from the classification of 
the neuropsychological function as impaired vs. not impaired. This method was also compared 
with other methods for classifying cognitive function by Shilling and colleagues (Shilling et al., 
2006). In this report, the authors compared 7 different methods for classifying 
neuropsychological function by performing the classification using each method on 92 breast 
cancer patients and 42 healthy controls. This report has shown that the method used by Wefel 
and colleagues (2004), when compared to other methods, neither overestimates nor 
underestimates the proportion of patients with cognitive impairment.  
II) Functional outcome was assessed using:  
• Modified Rankin scale (MRS) which incorporates mental and physical adaptations to 
the deficits resulting from neurologic injury using a scale from 0 (no symptoms at all) 
to 6 (death). Reliability and validity of the scale have been established in subjects 
suffering strokes (Sturm et al., 2002; Sulter, Steen, & De Keyser, 1999; van Swieten, 
Koudstaal, Visser, Schouten, & van Gijn, 1988). MRS was assessed on 3 and 12 
months after the onset of aneurysm rupture. 
• The Medical Outcomes Study 36-item Short-Form Health Survey version 2 (SF-36) 
physical component summary measures (Ware, Kosinski, & Dewey, 2000), ask 
subjects to indicate limitations to overall physical health using Likert-type scales. The 
score for the physical functioning component was generated by summing individual 
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items within that component was used in the analysis (question #3). Higher scores 
indicate more limitations in physical function. Validity for the SF-36 as a measure of 
overall physical health has been demonstrated in numerous patient populations 
(Failde & Ramos, 2000; Hollingworth et al., 2002; Riley et al., 2003).  
III) Mortality was tracked in the parent study through the subject’s clinic chart and, when 
necessary, by following up through the Social Security Death Index (SSDI) [Social security 
administration]. Due to the integrated inpatient and outpatient electronic record system at 
UPMC, information on the majority of deaths were available through medical records. 
3.7.4 Hunt and Hess (HH) grade 
Hunt and Hess grade is a 5-point scale that quantifies the severity of bleeding based on the 
presenting signs and symptoms; where grade I represents the least severe symptoms and V 
represent the most severe symptoms. We believe that patients with higher bleeding grades have 
higher risk for poor outcomes and thus Hunt and Hess grade was used as an independent variable 
in the analysis of specific aim #3.   
3.7.5 Confounding variables 
The following potential confounding variables were controlled for in this analysis.  
I) Mood was assessed in the parent study via depressive symptoms and anxiety. Patients with 
depression and anxiety have worse scores on neuropsychological tests suggesting an increased 
neuropsychological impairment in those patients compared to those without depression or 
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anxiety (Basso et al., 2007; Castaneda et al., 2008). Thus, controlling for depression and anxiety 
was warranted when measuring neuropsychological outcomes (Specific Aim #3) in order to 
ensure that the relationship between Hunt and Hess grade, DCI, and neuropsychological function 
outcomes was not confounded by depressive symptoms/anxiety.  
• Depressive symptoms were assessed using the Beck Depression Inventory II, a 21 item 
self-report measure on which subjects rate depressive symptoms and attitudes on a 5-
point Likert scale. The total score was used in the analysis. Validity has been established 
with the Structured Clinical Interview for DSM-IV Axis I Disorders (Arnarson, Olason, 
Smari, & Sigurethsson, 2008). 
• Anxiety was measured using The State-Trait Anxiety Inventory (STAI). The STAI is a 
40-item scale that comprises a trait anxiety scale and a state anxiety scale. The trait scale 
measures longstanding personality trait anxiety whereas the state scale measure 
temporary anxiety that is specific to certain situations. The state anxiety scale, which was 
used in this study, ranges between 20 and 80 with higher scores indicting greater levels of 
anxiety (Spielberger, Gorsuch, & Lushene, 1983). STAI has been used previously with 
aSAH patients as well as other patient populations (Al-Khindi et al., 2010; Karlsgodt, 
Lukas, & Elman, 2003; Passier et al., 2010). Validity and reliability for the STAI are well 
established in various patient populations (Rule & Traver, 1983; Smeets, Merckelbach, & 
Griez, 1996). The total score of the state scale was used in this study.  
II) Age: older age has been associated with poor neuropsychological and poor functional 
outcomes in patients with aSAH (Haug et al., 2010; Kreiter et al., 2002; Ohwaki et al., 2006). 
Therefore, age was controlled for when testing neuropsychological and functional outcomes 
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(Specific Aim #3) to ensure that the relationship between Hunt and Hess grade, DCI, and 
post-aSAH outcomes was not confounded by age. 
III) Years of education: having fewer years of education is associated with poor 
neuropsychological function in aSAH patients (Haug et al., 2010; Kreiter et al., 2002).  
Therefore controlling for number of years of education in Specific Aim #3 was important to 
make certain that these differences between subjects were due to neuropsychological 
impairment and not due to different levels of education.   
IV) Hunt and Hess grade: is a 5-point scale that quantifies the severity of bleeding based on 
the presenting signs and symptoms; where grade I represent the least severe symptoms and V 
represent the most severe symptoms. Higher bleeding severity grade measured by Hunt and 
Hess scale is associated with DCI (Frontera et al., 2009) and neuropsychological dysfunction 
(Kreiter et al., 2002; Otawara et al., 2009) and thus was controlled for to ensure that the 
relationship between CPP and DCI was not confounded by Hunt and Hess grade. Others have 
previously controlled for Hunt and Hess in similar analysis (Frontera et al., 2009). Hunt and 
Hess grade was controlled for in specific aims #2. However, it was used as an independent 
variable in specific aim #3.  
V) Aneurysm repair method: Functional and neuropsychological outcomes are affected by 
the method of aneurysm repair (i.e. endovascular coiling vs. surgical clipping) (Al-Khindi et 
al., 2010). Evidence from the International Subarachnoid Aneurysm Trial (ISAT), a 
multicenter randomized controlled trial that compared the impact coiling and clipping on 
patient after aSAH, suggests that endovascular coiling is associated with lower mortality and 
better outcomes at 1 year post aSAH (Scott et al., 2010). Further, Recent evidence suggests 
that surgical clipping is associated with higher risk for DCI compared to coiling (Dorhout 
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Mees et al., 2011). Therefore, aneurysm repair method was controlled for in specific aim #2 
and #3. This will eliminate the confounding effect of the aneurysm repair method.  
3.8 DATA ANALYSIS  
IBM SPSS 19 and Mplus 6 were used to perform the analyses. Data distributions were checked 
for normality, outliers, and linearity. Normality and outliers were examined subjectively through 
histograms, boxplots, normality probability plots, and objectively by the Shapiro-Wilk’s test. 
Multivariate outliers will be screened objectively by Mahalanobis distance and subjectively by 
bivariate plots. When outliers were found, verifications were made to ensure that these outliers 
were part of the sample and were not due to entry error. Linearity was examined subjectively by 
scatter plots and objectively by Box Cox transformation.  
3.8.1 Specific Aim #1 
To describe and examine CPP changes during the 14 days after aSAH in regard to: 
a. baseline, absolute values, daily changes (range, mean, standard deviation), 
proportion of CPP values <70 mmHg, and proportion of CPP values >100 
mmHg. 
Descriptive statistics and chart builder were used to graph all CPP values over 
time as well as daily ranges, means, and standard deviations.  
b. trends of CPP values over time. 
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Growth curve analysis was used to test whether repeated measured CPP 
trajectories over time are significant. This analysis was performed using IBM 
SPSS 19 using a 0.05 level of significance.  
3.8.2 Specific Aim #2 
To examine the relationship between DCI and the lowest decrement in CPP during the 12 
hours prior to DCI 
a. To examine the association between DCI and the lowest decrement in CPP 
during the 12 hours prior to DCI controlling for Hunt and Hess grade and 
aneurysm repair method. 
Binary Logistic regression was conducted with DCI as a dichotomous dependent 
variable and CPP as a ratio predictor variable to determine if CPP predicts DCI. 
This analysis was performed using IBM SPSS 19 and a 0.05 level of significance 
controlling for Hunt and Hess grade and aneurysm repair method.  
b. To explore the threshold of CPP value associated with DCI.  
Receiver operating characteristic (ROC) curve was conducted to estimate the area 
under the curve and find the cutoff value for CPP that is associated with DCI. The 
cut-off CPP value was determined by the value that has the highest level of 
sensitivity and specificity for DCI.  
c. To determine whether minimum CPP values are related to the onset of DCI 
controlling for Hunt and Hess grade and aneurysm repair method.  
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Accelerated failure time model using SAS 9.2 was used to determine the 
relationship between CPP and onset of DCI.   
3.8.3 Specific Aim #3 
To determine whether DCI mediates the relationship between Hunt and Hess grade and 
neuropsychological outcomes, functional outcomes, physical outcomes, and death post 
aSAH controlling for age, aneurysm repair method, years of education, anxiety and 
depression. 
In order to determine whether DCI mediates the relationship between Hunt and Hess grade and 
outcomes, Mplus 6 was used to conduct bias corrected bootstrapping test. Bootstrapping test is a 
nonparametric procedure and, unlike Sobel test, it does not assume normality of sampling 
distribution of the indirect effects in the mediation model. Also it is not based on large sample 
theory and typically requires less sample size than Sobel test does. Thus, it can be conducted 
more confidently with small sample size. Moreover, bootstrapping, unlike Baron and Kenny 
approach, it does not require zero measurement error (Preacher & Hayes, 2004). We expected 
measurement error in Hunt and Hess grade and DCI assessment as well as non-normal 
distribution of the indirect effects in the mediation model. Therefore, bootstrapping was the best 
approach for analyzing data in this specific aim. The level of significance was the standard 0.05. 
The comparisons in the study aim were made a priori and thus no correction for the inflation in 
type I error was made.  
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3.9 STUDY LIMITATIONS 
The current study has several limitations. First, there might be discrepancy between the MAP 
measured invasively using arterial lines and those measured noninvasively using blood pressure 
cuff. It was not be possible to limit subjects to those with an arterial line because it would 
significantly decrease available subjects. UPMC clinicians tend to use noninvasive monitoring 
once the patient stabilized to lower the risk of complications. Second, due to the variability in 
days of follow up and variability of subjects’ conditions, there may be different numbers of CPP 
values for different subjects. However, the statistical analyses in this study do not require the 
same number of observations for every subject; thus, it is unlikely to change our results. Third, it 
is likely that more subjects with a higher aSAH grade had an external ventricular drain which 
could limit the generalizability to high grade aSAH, however, the current analysis controlled for 
the severity of aSAH in all multivariate analyses. Fourth, CPP values were recorded 
intermittently. Continuous CPP monitoring is more likely to capture all abnormal values; 
however, this was not be feasible in our subjects due to the nature of ICP measurement at the 
bedside. The EVDs used to measure ICP needed to be clamped intermittently to obtain valid ICP 
measurements. Further, the EVD in these subjects was open most of their time for CSF drainage, 
while the ICP was measured only when the EVD was clamped. Therefore, the ICP measurement 
via the EVD might not represent the precise ICP values that the subject had most of the day 
while the EVD was open. Finally, the above mentioned method for analyzing CPP does not 
distinguish between patients who had few episodes but long duration of low CPP and those who 
had more frequent and shorter episodes of low CPP. However, since our analysis has used the 
lowest CPP value measured 12 hours prior to DCI, the number of CPP measurements will 
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typically be 6 values for those 12 hours. Therefore, it is likely that the chance of encountering the 
situations of few episodes but long duration of low CPP versus more frequent and shorter 
episodes of low CPP was minimal and did not affect our findings.  
3.10 HUMAN SUBJECTS/ETHICAL CONSIDERATIONS 
This secondary analysis that has utilized data collected for the parent study R01 (NR004339-10) 
and approved by the Institutional Review Board (IRB) at the University of Pittsburgh 
(REN11040212 / IRB021039). The risk in the current study was minimal and was restricted to 
potential loss of confidentiality. All subjects have study identification numbers and data for the 
current study was analyzed after it was de-identified. Data was kept protected in a secure 
password protected computer in locked office. During the consent procedure for the parent study, 
subjects were informed that their participations are completely voluntary and the decision 
whether to enroll in the study will not affect their standards of care. There was no exclusion 
based on gender, ethnicity or race.  
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4.0  RESULTS  
The purpose of this study was to examine the relationship between CPP, DCI, and onset of DCI 
and to test whether DCI mediates the relationship between HH grade and poor outcomes after 
aSAH. Two articles describing the results of this study have been prepared for submission to 
Neurocritical Care  (Aim 1) and Stroke (Aim 2 and 3) are appended to this chapter.  
4.1 FINDINGS RELATED TO AIM 1 
Aim 1: To examine the temporal profiles of CPP changes after SAH. 
Subjects (n=238) were relatively young (53 ± 11.4 years), predominantly female (69%) and 
Caucasian (88%). Other clinical characteristics are shown on table 3. At baseline, the mean CPP 
was 70±17.5 mmHg with a range of 30-129 mmHg. The minority (28%) had a CPP < 60 mmHg 
and the majority (72%) had CPP values that ranged from 60 to 160 mmHg. Patterns of change 
for the 16 subjects randomly selected from the sample are shown in Figures 2a-2c.  After 
admission, CPP increased gradually from day 1 to day 5, and stabilized after day 5. The same 
trend was observed using the daily mean and 95% confidence interval of CPP values (Figure 3). 
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The same figure also shows that the width of 95% confidence interval was narrow until day 10, 
indicating controlled MAP and ICP.  
When daily means of CPP, MAP, and ICP were charted (Figure 4), we observed that the 
trend of CPP and followed a similar trend of MAP, suggesting a greater influence of MAP on 
CPP compared to ICP. To objectively and quantitatively test that observation, we performed 
Pearson correlation to compare correlation coefficients between MAP and CPP vs. ICP and CPP 
(Table 4). We found that the correlation coefficients of MAP and CPP were higher than the 
coefficients of ICP and CPP over the observation period.  
Figure 5 shows the percentage of CPP values < 70 mmHg and > 100 mmHg. 
Approximately, 65% of CPP values were < 70 mmHg immediately after admission; conversely, 
only 2% of CPP values were > 100 mmHg after admission. The percentage of CPP values < 70 
mmHg began to decrease until day 5 and then stabilized around 20% after day 5. Likewise, the 
percentage of CPP values > 100 mmHg began to increase until day 5 and then stabilized around 
20% after day 5.  
In addition, we objectively tested whether change rates were significant over time using 
growth curve analysis (Table 5) (Mirman, Dixon, & Magnuson, 2008). In Model 1, the interclass 
correlation coefficient was 0.39 [133.73/(133.73 +206.69)], indicating that 39% of the total 
variation in CPP values was due to between subject differences.  In Model 2, there was a 
significant linear increase in CPP values over time (β = 0.06, SE = 0.006, p <0.001). The mean 
estimated initial CPP for the sample was 72.46 mmHg whereas the change rate was positive 
(0.06), indicating an increase of CPP values over time. Comparing variation in initial CPP values 
between model 1 and model 2, there was a significant decline in the residual variance of 38.29 
(206.68 to 168.39). Thus, 18.5% (38.29/206.68) of the within subject variation in CPP values 
  
 
62 
was associated with linear rate of change. The covariance ( = -0.52, SE = 0.09, p <0.001) 
between the intercept and the linear change parameter was negative. This indicates that subjects 
with high CPP values had a slower rate of linear increase, while those with low CPP values had a 
faster rate of linear increase. In Model 3, all growth parameters were significant (p<0.001). 
Between-subjects variations were significant in all (baseline, linear, quadratic) time trajectories. 
The grand mean of initial CPP was 64.11 (β = 64.11, SE = 0.83, p <0.001). The significant linear 
effect for the CPP was positive (β = 0.22, SE = 0.007, p <0.001), suggesting that the rate of linear 
change increased over time. The rate of quadratic change (-0.0006) was very small compared to 
the linear change trajectory (0.06). These findings support a pattern of change that varied after 
admission; CPP values increased after admission, but this trend slowed later in the hospital stay 
(approximately after day 5).   
Lastly, we found that subjects who had greater percentages of CPP values > 100 mmHg 
and > 110 mmHg had greater odds for having DCI. For every 10% increase in the proportion of 
CPP values > 100 and > 110 mmHg the odds of DCI increased by 1.21 and 1.43, respectively 
(Table 6).   
  
4.2 FINDINGS RELATED TO AIM 2 
This analysis included 211 subjects, who were relatively young (53±11 years), predominantly 
female (66%) and white (88%). Mean education was 13 years at 3 (SD=2) and 12 (SD=2.5) 
months. Approximately, 62% underwent aneurysm coiling, 67% had a poor HH grade (3-5), and 
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42% experienced DCI.  DCI could not be determined for 13 patients (6%) due to inability to 
assess neurological decline due to sedation or coma. The mean value for CPP was 53±17 mmHg. 
The mean BDI score was 10±8 at 3 months and 12±10 at 12 months. The mean State Anxiety 
score was 47±6 at 3 months and 45±6 at 12 months.  
Logistic regression was performed on DCI as a function of age, gender, HH grade [good 
(1-2) or poor (3-5)], aneurysm treatment option (clipping vs. coiling), and CPP (Table 8). The 
overall model significantly predicted DCI; χ2(5, N=196) = 71.43, p < 0.001, Nagelkerke R2 = .41. 
There was a significant positive relationship between CPP and DCI. For every 10 mmHg 
increase in CPP, the odds of DCI increased by 2.78 (95%CI 2.00-3.87). Furthermore, the mean 
value for CPP was significantly greater for subjects with DCI (64.6±17), compared to those 
without DCI (46±11), p<.001.  
The mean time for DCI diagnosis was 6±2.3 days after bleeding. This analysis controlled 
for age, gender, aneurysm repair method, and Hunt and Hess grade. Table 9 shows that the 
estimate of CPP was negative (-0.283) indicting that high CPP values are associated with shorter 
time to DCI (p<0.0001).  
4.3 FINDINGS RELATED TO AIM 3 
Data on neuropsychological outcomes were available for 61-77 subjects. Missing data resulted 
from time of recruitment (neuropsychological assessments were not initiated until 2003), loss to 
follow up, death, and refusal. Approximately one third had a poor MRS at 3 (32%) and 12 (30%) 
months and impaired neuropsychological function at 3 (33%) and 12 (17%) months. Mean SF36 
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score was 20±5 and 22±5 at 3 and 12 months, respectively. Approximately, one-fourth of 
subjects were dead at 3 (26%) and 12 (29%) months. The direct effects between HH grade and 
outcomes were tested before testing the mediation effect. Mediation was tested only when the 
direct effect was significant. HH grade was significantly related to mortality and functional 
outcomes at 3 and 12 months, but not physical or neuropsychological function (controlling for 
age, aneurysm repair method, education, depression and anxiety). However, DCI did not 
significantly mediate the relationship between HH grade and functional outcome or death at both 
3 and 12 months (Table 10). 
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5.0  RESULTS MANUSCRIPT #1 
Temporal Profiles of Cerebral Perfusion Pressure After Subarachnoid Hemorrhage 
5.1 ABSTRACT 
Introduction: Insufficient cerebral perfusion pressure (CPP) after aneurysmal subarachnoid 
hemorrhage (aSAH) can impair cerebral blood flow (CBF). We examined the temporal profiles 
of CPP change and tested whether these profiles were associated with delayed cerebral ischemia 
(DCI).  
Method: CPP values were retrospectively reviewed for 238 subjects. Intracranial 
pressure and mean arterial pressure values were obtained every 2 hours for 14 days. Induced 
hypertension was utilized to prevent vasospasm. The linear and quadratic CPP change over time 
were tested using growth curve analysis. Multivariable logistic regression was utilized to 
examine the association between DCI and percentages of CPP values >110, >100, <70, and <60 
mmHg. DCI was defined as neurological deterioration due to impaired CBF.  
Results: Between-subjects differences accounted for 39% of variation in CPP values. 
There was a significant linear increase in CPP values over time (β =0.06, SE=0.006, p<0.001). 
The covariance ( = -0.52, SE=0.09, p<0.001) between initial CPP and linear parameter was 
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negative, indicating subjects with high CPP on admission had a slower rate of increase whereas 
those with low CPP had a faster rate of increase. For every 10% increase in the proportion of 
CPP>100 mmHg or >110 mmHg, the odds of DCI increased by 1.21 and 1.43, respectively.  
Conclusion: The longer the time patients spent with high CPP the greater the odds for 
DCI. When used prophylactically, induced hypertension contributes to higher CPP values. Based 
on the CPP trends and correlations observed, induced hypertension may not confer expected 
benefits in patients with aSAH.  
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5.2 INTRODUCTION 
Impairment of cerebral blood flow is common in individuals who survive aneurysmal 
subarachnoid hemorrhage (aSAH). Causes include a sudden increase in intracranial pressure 
(ICP) that results from bleeding and other secondary complications, cerebrovascular infarction, 
and vasospasm (Ansar & Edvinsson, 2008; Dankbaar et al., 2009; Gobiet, Grote, & Bock, 1975; 
Heinsoo et al., 1998; Nornes & Magnaes, 1972). Delayed cerebral ischemia (DCI) is often 
attributed to focal ischemia. When cerebral blood flow is impaired due to a focal perfusion 
deficit (e.g. infarction or vasospasm), collateral circulation may be recruited to keep tissue 
potentially recoverable (ischemic penumbra). In global ischemia (e.g. inadequate cerebral 
perfusion pressure), blood flow in the collateral circulation is also impaired which limits ability 
to preserve flow to brain tissue (Roach et al., 2010). 
Focal perfusion deficits after aSAH, such as cerebral infarction and vasospasm, have 
been extensively studied as potential causes of impaired blood flow (Carlson & Yonas, 2009; 
Etminan et al., 2011; Frontera et al., 2009; Juvela & Siironen, 2012; Macdonald et al., 2007). 
Less attention has been given to global cerebral perfusion. Insufficient cerebral perfusion 
pressure (CPP) is associated with poor outcomes after aSAH (Rasulo et al., 2012). This effect 
can be worse when cerebral autoregulation is impaired; a complication that is common after 
aSAH (Carrera et al., 2010; Jaeger, Soehle, Schuhmann, & Meixensberger, 2012). When cerebral 
autoregulation is impaired, small changes in CPP might be poorly tolerated by the brain. To 
avoid further injury to the brain, it is important to characterize changes in CPP after aSAH and 
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attempt to identify determinants of this change. The purpose of this study was to examine 
temporal profiles of CPP change after aSAH and test whether these profiles are associated with 
DCI.  
5.3 METHODS 
5.3.1 Sample and Setting 
This descriptive longitudinal study included 238 patients with aSAH recruited in an ongoing 
NIH-funded study (R01NR004339). Subjects were admitted to the neurovascular intensive care 
unit (NICU) at the University of Pittsburgh Medical Center (UPMC) between May 1999 and 
October 2011. Computed tomography (CT) was used to diagnose subarachnoid hemorrhage; 
cerebral angiography was used to diagnose the presence of an aneurysm. Inclusion criteria for 
the parent study were: 1) age of 21 to 75 years; 2) spontaneous aneurysm rupture, and 3) Fisher 
grade ≥2. In addition to these criteria, patients in the current study were required to have an 
external ventricular drain (EVD) for ICP measurement. Patients with a preexisting chronic 
neurologic deficit or traumatic or mycotic aneurysm were excluded. Subjects were enrolled 
during the first five days after aSAH; data collection continued for 14 days after bleeding or until 
discharge.   
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5.3.2 Cerebral perfusion pressure (CPP) 
CPP was defined as the pressure gradient between mean arterial pressure (MAP) and ICP 
(Alvarez del Castillo, 2001). MAP and ICP values were retrospectively obtained from the 
medical record. Standards of care required MAP and ICP values be recorded every 2 hours, 
providing a minimum of 12 values each day, and more frequently if subjects exhibited 
neurologic or systemic instability. On the day of admission and discharge, fewer CPP 
measurements were available depending on time of admission or discharge. Data collection 
continued for 14 days after the bleeding onset. When a subject was admitted more than one day 
after bleeding or the subject was discharged before the 14-day period, CPP values were available 
for <14 days. MAP was measured either invasively using an arterial line or noninvasively using a 
blood pressure cuff. ICP was measured invasively by an EVD.  
5.3.3 Delayed cerebral ischemia (DCI) 
DCI was defined as neurological deterioration due to impaired cerebral blood flow not 
attributable to rebleeding, seizure, hydrocephalus, or cerebral edema. When both neurological 
deterioration and indications of impaired cerebral blood flow existed, a diagnosis of DCI was 
made. Neurological deterioration was defined as one of the following: a) deterioration in 
Glasgow coma scale score, b) new focal deficit, c) deterioration in pupillary reaction, or d) 
deterioration in the NIH Stroke Scale. Within 12 hours of the neurological deterioration (either 
before or after), assessment of cerebral blood flow was performed. Impairment in cerebral blood 
flow was indirectly assessed using the following surrogate measures: transcranial Doppler 
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(TCD), CT and CT perfusion scans, or cerebral angiography. Daily TCD exams indicated 
impaired cerebral blood flow if systolic middle cerebral artery velocity was >200 ml/second or 
Lindegaard ratio >3.0. Head CT and CT perfusion scans were reviewed by a radiologist for the 
presence of cerebral ischemia and/or infarction. Cerebral angiography studies were reviewed for 
vascular narrowing, with narrowing > 25% indicating clinically significant vasospasm. When 
neurological deterioration could not be assessed due to coma or sedation and DCI status could 
not be determined subjects were excluded from the analysis.   
5.3.4 Statistical analysis  
Descriptive statistics using IBM SPSS 19 were used to characterize CPP changes. Admission 
(baseline) CPP values were defined as the first CPP value measured in the first 24 hours after 
bleeding was described. Admission CPP was divided into three categories using the cutoff values 
of <60 mmHg, 60-160 mmHg, and >60 mmHg. Next, all CPP values for 16 randomly selected 
subjects were used to create line charts of CPP values versus time profiles over the observation 
period and daily means and confidence intervals of CPP values were charted. In addition, daily 
means of CPP, MAP, and ICP were charted to determine whether ICP or MAP had a greater 
influence on CPP. This analysis was followed up with quantitative assessment of this influence 
using Spearman correlation coefficients. Furthermore, the percentages of CPP values < 70 
mmHg, and percentages of CPP values > 100 mmHg were obtained. Growth curve analysis was 
used to objectively examine the linear and quadratic rate of change of CPP over time. Three 
models were utilized (Table 5). Model 1, an unconditional mean model was the baseline model 
that examined individual variations of CPP values with no regard to time. Because it had no time 
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component, this model was used to assess the variation in CPP values due to between-subjects 
differences. Model 2, an unconditional linear growth model, examined individual 
variations/changes over time. This model was used to assess within-subject variations. Model 3, 
a quadratic growth curve model, was utilized because individual change trajectories of CPP were 
nonlinear; therefore using a higher order polynomial model was warranted. Lastly, the 
percentages of CPP values <70, <60, >100, and >110 mmHg were calculated and used as 
predictors of DCI. Because data were obtained intermittently and not continuously, these 
percentages were used as surrogate measures for the length of time subjects experienced low or 
high CPP. Each percentage was analyzed in a separate multivariable logistic regression model 
controlling for aneurysm treatment (endovascular coiling vs. surgical clipping), and Hunt and 
Hess grade (low grade: 1-2, high grade: 3-5).  
5.4 RESULTS 
Subjects (n=238) were middle age adults (53 ± 11.4 years), predominantly female (69%) and 
Caucasian (88%). DCI data were available for 211 subjects, but deterioration in neurological 
exam could not be evaluated in 13 subjects. DCI was diagnosed in 41.9% of the remaining 
subjects (n=198). Other clinical characteristics are shown in table 3.  
At baseline, the mean CPP was 70±17.5 mmHg with a range of 30-129 mmHg. The 
minority (28%) had a CPP < 60 mmHg and the majority (72%) had CPP values that ranged from 
60 to 160 mmHg. Patterns of change for the 16 subjects randomly selected from the sample are 
shown in Figures 2a-2c.  After admission, CPP increased gradually from day 1 to day 5, and 
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stabilized after day 5. The same trend was observed using the daily mean and 95% confidence 
interval of CPP values (Figure 3). The same figure also shows that the width of 95% confidence 
interval was narrow until day 10, indicating controlled MAP and ICP.  
When daily means of CPP, MAP, and ICP were charted (Figure 4), we observed that the 
trend of CPP and followed a similar trend of MAP, suggesting a greater influence of MAP on 
CPP compared to ICP. To objectively and quantitatively test that observation, we performed 
Pearson correlation to compare correlation coefficients between MAP and CPP vs. ICP and CPP 
(Table 4). We found that the correlation coefficients of MAP and CPP were higher than the 
coefficients of ICP and CPP over the observation period.  
Figure 5 shows the percentage of CPP values < 70 mmHg and > 100 mmHg. 
Approximately, 65% of CPP values were < 70 mmHg immediately after admission; conversely, 
only 2% of CPP values were > 100 mmHg after admission. The percentage of CPP values < 70 
mmHg began to decrease until day 5 and then stabilized around 20% after day 5. Likewise, the 
percentage of CPP values > 100 mmHg began to increase until day 5 and then stabilized around 
20% after day 5.  
In addition, we objectively tested whether change rates were significant over time using 
growth curve analysis (Table 5) (Mirman et al., 2008). In Model 1, the interclass correlation 
coefficient was 0.39 [133.73/(133.73 +206.69)], indicating that 39% of the total variation in CPP 
values was due to between subject differences.  In Model 2, there was a significant linear 
increase in CPP values over time (β = 0.06, SE = 0.006, p <0.001). The mean estimated initial 
CPP for the sample was 72.46 mmHg whereas the change rate was positive (0.06), indicating an 
increase of CPP values over time. Comparing variation in initial CPP values between model 1 
and model 2, there was a significant decline in the residual variance of 38.29 (206.68 to 168.39). 
  
 
73 
Thus, 18.5% (38.29/206.68) of the within subject variation in CPP values was associated with 
linear rate of change. The covariance ( = -0.52, SE = 0.09, p <0.001) between the intercept 
and the linear change parameter was negative. This indicates that subjects with high CPP values 
had a slower rate of linear increase, while those with low CPP values had a faster rate of linear 
increase. In Model 3, all growth parameters were significant (p<0.001). Between-subjects 
variations were significant in all (baseline, linear, quadratic) time trajectories. The grand mean of 
initial CPP was 64.11 (β = 64.11, SE = 0.83, p <0.001). The significant linear effect for the CPP 
was positive (β = 0.22, SE = 0.007, p <0.001), suggesting that the rate of linear change increased 
over time. The rate of quadratic change (-0.0006) was very small compared to the linear change 
trajectory (0.06). These findings support a pattern of change that varied after admission; CPP 
values increased after admission, but this trend slowed later in the hospital stay (approximately 
after day 5).   
Lastly, we found that subjects who had greater percentages of CPP values > 100 mmHg 
and > 110 mmHg had greater odds for having DCI. For every 10% increase in the proportion of 
CPP values > 100 and > 110 mmHg the odds of DCI increased by 1.21 and 1.43, respectively 
(Table 6).   
5.5 DISCUSSION 
Findings from this analysis can be summarized as follows: 1) CPP values were highly influenced 
by treatment, mainly induced hypertension, 2) MAP had more influence on CPP than ICP, and 3) 
the higher the proportion of CPP values > 100 mmHg and > 110 mmHg the greater the risk for 
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DCI.  Understanding temporal profiles of CPP after aSAH is important especially when cerebral 
autoregulation is impaired. When cerebral autoregulation is impaired, cerebrovascular resistance 
becomes relatively constant an outcome that results in cerebral blood flow becoming highly 
dependent on CPP. In this situation, small changes in CPP can result in ischemic events. To our 
knowledge this is the first report to extensively describe and objectively test temporal profiles of 
CPP over time in patients with aSAH. 
Our observation that 28% of patients had baseline CPP values < 60 mmHg suggests that 
approximately one third of aSAH patients may have insufficient CPP on admission. For these 
patients, CPP values began to increase after admission, a change likely due to treatment-induced 
hypertension to prevent vasospasm and drainage of CSF to control ICP. Standards of care in our 
subjects included a cap of 120 mmHg for systolic blood pressure before securing the aneurysm 
that was raised to 180 mmHg after securing the aneurysm. Also, the EVD was placed at 25 cm 
above the midbrain before securing the aneurysm and lowered to 10 cm after securing the 
aneurysm. Hence, once the aneurysm was secured more CSF was drained (lower ICP) and 
prophylactic hypertension was induced creating higher CPP.  
In Figure (4) MAP showed a stepwise increment after admission, the same trend was 
noticed in CPP values (range of daily mean: 80.6 – 99.1 mmHg). However, ICP values were 
relatively constant throughout the observation period (range of the daily mean: 11.4-15.3 
mmHg). These findings suggest that MAP had a greater influence on CPP than ICP, an 
observation that was corroborated by higher correlation coefficients for MAP and CPP compared 
to ICP and CPP (Table 4).  
Changes in MAP can be explained, in part, by the catecholamine surge that is known to 
occur after aSAH and continue for up to 24 hours after bleeding (Ogura et al., 2012). In addition, 
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most subjects were managed using induced hypervolemia and vasopressors with the goal of 
inducing hypertension after aneurysm treatment and preventing vasospasm. We retrospectively 
and indirectly evaluated intravascular volume using central venous pressure (CVP) as a surrogate 
measure (Figure 6). The daily mean of CVP ranged from 9.05 to 11.42 mmHg indicating that 
subjects were hypervolemic (> 8 mmHg) during this time period. Hence, it is likely that the trend 
observed in CPP changes was strongly influenced by post-injury care and, particularly, induced 
hypertension and intravascular volume expansion. This speculation was corroborated by the 
observation that patients with a high CPP had a slower change rate and those with a low CPP a 
faster change rate. This suggests that treatment was likely more aggressive in patients with a low 
CPP on admission, either due to a high ICP or a low MAP, both of which are avoided after 
aSAH.  
Our data show that patients who had a higher proportion of their CPP values > 100 and > 
110 mmHg had greater odds of experiencing DCI. It remains unclear if this finding was a 
complication of therapy or a marker of treatment in sicker patients who required more aggressive 
treatment. If a complication of induced hypervolemia and hypertension, our findings suggest that 
aggressive therapeutic hypertension might not actually be therapeutic. The CVP values we 
observed also tend to confirm that subjects were hypervolemic during the observation period. 
 Previous reports have documented adverse effects of induced hypervolemia such as 
pulmonary edema and decrease cerebral oxygen delivery (in case of hemodilution) (Ekelund et 
al., 2002). Our findings suggest that induced hypertension is not without complication. 
Minimizing the time during which subjects are exposed to this treatment may be warranted to 
prevent DCI. Limiting the use induced hypertension and hypervolemia as treatment options to 
periods of vasospasm may reduce complications. Our findings also raise an important 
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consideration regarding the safety of induced hypertension. Current standards of care do not 
identify safe limits for hypertension in aSAH patients or take into account the baseline blood 
pressure when using hypertension as a treatment for vasospasm.  Future studies are needed to 
better define optimal treatment targets. 
This study has several limitations. CPP measurements were intermittent, rather than 
continuous. Continuous CPP and ICP monitoring would capture more values, but was not 
possible in our subjects as ICP was measured by an EVD, which needed to be clamped 
periodically to obtain valid ICP values. However, using this method, CPP values were obtained 
by the bedside nurse; therefore, they did not include artifacts often found in continuous 
monitoring. All subjects had EVDs, an intervention commonly used in high bleeding grades. 
Findings may therefore not be generalizable to patients with low bleeding grades or without 
EVDs. The EVD was open most of the time to allow for CSF drainage and ICP was measured 
only when the EVD was clamped. Therefore, the ICP measurement via the EVD might not 
represent the ICP value present the majority of time while the EVD was open. Lastly, data were 
collected over 12 years; therefore changes in standards of care may have confounded our 
findings.  
5.6 CONCLUSIONS 
In patients enrolled in this study, CPP increased significantly over time. This trend was most 
evident in the first 5 days after bleeding and likely influenced by treatment, particularly induced 
hypertension and hypervolemia. We observed that odds of DCI increased with higher 
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proportions of CPP >100 and >110 mmHg. This suggests that the prophylactic use of induced 
hypertension and hypervolemia results in increased CPP values. Based on the trends and 
correlations of CPP found in this study, we conclude that induced hypertension and 
hypervolemia may not confer expected benefits in patients with aSAH. Therefore, the use of 
these treatment options may need to be limited to treat, rather than prevent, vasospasm in order 
to reduce complications. This study suggests the need to further investigate the safety of induced 
hypertension and examine limits for the length of exposure to this treatment.  
Source of Funding: NIH National Institute of Nursing Research (R01NR004339), Nightingale 
Award of Pennsylvania, and Neuroscience Nursing Foundation 
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Table 3. Subjects' clinical characteristics (n=238) 
 
 
 
 
 
 
Characteristics Percent 
Hunt and Hess grade  
Grade 1 
Grade 2 
Grade 3 
Grade 4 
Grade 5 
 
 
6 
28 
40 
20 
6 
Fisher Grade 
Grade 2 
Grade 3 
Grade 4 
 
 
32 
48 
20 
Aneurysm site 
           Anterior circulation  
           Posterior circulation  
 
 
82 
18 
Prophylactic Magnesium  
 
78 
Aneurysm repair  
          Endovascular coiling 
          Surgical clipping  
 
63 
35 
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Figure 2a. All CPP values for 16 randomly selected subjects (days 1-5) 
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Figure 2b. All CPP values for 16 randomly selected subjects (days 6-10) 
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Figure 2c. All CPP values for 16 randomly selected subjects (days 11-14) 
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Figure 3. Daily means and 95% confidence intervals for CPP 
  
  
 
83 
 
Table 4. Pearson correlation coeffecients for the relationship between CPP, ICP, and MAP 
Day From Injury             ICP MAP 
Day 1 -.331* .873* 
Day 2 -.508* .892* 
Day 3 -.410* .902* 
Day 4 -.340* .884* 
Day 5 -.192* .910* 
Day 6 -.279* .916* 
Day 7 -.284* .951* 
Day 8 -.303* .926* 
Day 9 -.368* .936* 
Day 10 -.370* .952* 
Day 11 -.382* .964* 
Day 12 -.458* .948* 
Day 13 -.341* .967* 
Day 14 -.408* .975* 
* p < .001 
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Figure 4. Daily means of ICP, CPP, and MAP 
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Figure 5.  Percentages of CPP<70 mmHg and >100 mmHg 
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Table 5. Growth curve analysis of CPP changes over time 
Parameters 
 
Model 1 Model 2 Model 3 
Fixed effect 
      Intercept 
         SE 
         p-value 
      Linear time term 
         SE 
          p-value 
      Quadratic time term 
         SE 
          p-value 
 
79.64 
(.76) 
<.0001 
-- 
-- 
-- 
-- 
-- 
-- 
 
72.47 
.82 
<.0001 
.06 
.006 
<.0001 
-- 
-- 
-- 
 
 
64.11 
.83 
<.0001 
.22 
.007 
<.0001 
-.0006 
.00002 
<.0001 
Random effect 
      
      
      
       
 
133.73 
-- 
-- 
206.68 
 
148.04 
.007 
-.52 
168.39 
 
 
142.91 
.007 
-.52 
157.53 
Overall Model test 
      -2LL 
      AIC 
      BIC  
 
193744.016 
193750.016 
193774.223 
 
189534.872 
189542.872 
189575.147 
 
188018.012 
188026.012 
188058.287 
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Table 6. Multivariable logistic regression for DCI as a function of percentage of CPP 
Variables Estimates OR(95% CI)* p value 
Percentage of CPP value >100 .19 1.21(1.01-1.56) .045 
Percentage of CPP values >110 .36 1.43(1.01-2.05) .044 
Percentage of CPP values <70 -.06 .95(.83-1.07) .392 
Percentage of CPP values <60 -.05 .95(.78-1.15) .610 
Every variable was used in a separate multivariable model controlling for Hunt and Hess grade 
and aneurysm repair method.  
* OR and 95% CI were calculated for every 10% increase in the percentage of CPP values.  
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Figure 6. Daily CVP means showing hypervolemia (CVP>8) during the observation period 
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6.0  RESULTS MANUSCRIPT #2 
Association of Cerebral Perfusion Pressure With Delayed Cerebral Ischemia After 
Aneurysmal Subarachnoid Hemorrhage 
6.1 ABSTRACT 
Background and Purpose: Delayed cerebral ischemia (DCI) and Hunt and Hess (HH) grade are 
known risk factors for poor outcomes after aneurysmal subarachnoid hemorrhage (aSAH). The 
relationship between DCI and global cerebral perfusion is unclear. Whether DCI mediates the 
relationship between HH grade and outcomes remains unknown. This study aimed to investigate 
the relationship between cerebral perfusion pressure (CPP), DCI, HH grade, and outcomes 
following aSAH.  
Methods: DCI was defined as clinical deterioration due to impaired cerebral blood flow. 
The relationship between minimum CPP (within12 hours prior to DCI), DCI onset, and DCI 
were tested using logistic regression and the accelerated failure time model. The mediation effect 
of DCI on relationships between HH grade and outcomes was tested using the bootstrap 
confidence interval. Three and 12-month outcomes included mortality, neuropsychological, 
functional (modified Rankin scale [MRS]) and physical (SF36) outcomes. 
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Results: DCI occurred in 42% of subjects (n=211). One-third of subjects had a poor MRS 
at 3 (32%) and 12 (30%) months and impaired neuropsychological function at 3 (33%) and 12 
(17%) months. For every 10 mmHg increase in CPP, the odds of DCI increased by 2.78 (95% CI 
2.00-3.87). High CPP was associated with earlier onset of DCI (p<0.0001). DCI did not mediate 
the relationship between HH grade and functional outcome or death. 
Conclusions: The positive relationship between CPP and DCI was likely due to induced 
hypertension and hypervolemia. Findings raise concerns about safety of induced hypertension 
and the need for determining limits for hypertension, which current guidelines lack.  
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6.2 INTRODUCTION 
Mortality and severe morbidity after aneurysmal subarachnoid hemorrhage (aSAH) are often 
associated with delayed cerebral ischemia (DCI), a complication that occurs in 19-63% of 
patients with aSAH (Carrera, Schmidt, Oddo, Fernandez, et al., 2009; Carrera, Schmidt, Oddo, 
Ostapkovich, et al., 2009; Claassen et al., 2001; Frontera et al., 2009; Hop et al., 1999; Lanterna 
et al., 2010; Yousef et al., 2010). DCI typically occurs 3-15 days after the initial bleeding and 
peaks on day 7 (Claassen et al., 2001; van Gijn et al., 2007). DCI is associated with poor 
outcomes and numerous complications, including myocardial infarction, arrhythmias, pulmonary 
edema, fever, cerebral edema, inability to perform activities of daily living, cognitive 
impairment, and death (Frontera et al., 2009; Springer et al., 2009). Thus, prevention of DCI is 
key to improving outcomes after aSAH.  
DCI occurs as a result of impairment in cerebral blood flow or hypoperfusion; a 
complication that has been reported previously after aSAH (Cahill et al., 2006; Frontera et al., 
2009). Cerebral hypoperfusion can occur locally due to focal vascular alterations, such as 
vasospasm and mircothrombi, or globally due to pressure/flow deficits, such as inadequate 
cerebral perfusion pressure (CPP). Current interventions focus on treatment of focal vascular 
changes (e.g. vasospasm), yet these interventions have had limited success (Rinkel & Klijn, 
2009). Attempts to prevent vasospasm and microthrombi using endothelin antagonists and 
antiplatelet administration have not resulted in a significant reduction in DCI or improvement in 
outcomes (Dorhout Mees et al., 2007, 2008; A. Kramer & Fletcher, 2009; Macdonald et al., 
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2008; van den Bergh et al., 2006; van den Bergh et al., 2009). Most patients with moderate to 
severe angiographic vasospasm are asymptomatic (Vergouwen, Ilodigwe, et al., 2011), 
suggesting that vasospasm and DCI are not strongly correlated and therefore treatment of focal 
perfusion deficits may be insufficient to prevent DCI.  
Exploring the relationship between DCI and CPP therefore appears warranted. It is 
unclear, for example, if risk for infarction that leads to DCI varies with a change in CPP. 
Furthermore, severity of symptoms at admission measured by Hunt and Hess (HH) grade is 
known to be associated with complications and poor outcomes (Frangiskakis et al., 2009; 
Mustonen et al., 2008). However, the mechanistic link between HH grade and poor outcomes 
remains unclear. It is unknown whether DCI can explain, in part, this relationship. The purpose 
of this study was to investigate the relationship between DCI and CPP and determine if DCI 
mediates the relationship between HH grade and outcomes after aSAH.  
 
6.3 METHODS 
6.3.1 Sample and setting 
Subjects were patients with aSAH admitted to a regional medical center between May 1999 and 
October 2011 and enrolled in an ongoing NIH study (R01NR004339). Subarachnoid hemorrhage 
was diagnosed using computed tomography (CT) and presence of an aneurysm was diagnosed 
using digital subtraction angiography. Eligible subjects were 21-75 years of age with a 
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spontaneous aneurysm rupture and Fisher grade ≥2. In addition to the eligibility criteria of the 
parent study, the current study included patients with external ventricular drain (EVD) for 
intracranial pressure (ICP) measurement. Exclusion criteria included preexisting chronic 
neurologic deficit or traumatic or mycotic aneurysm. Subjects were recruited within the first 5 
days after aSAH and followed for 14 days after aneurysm rupture or until discharge.   
6.3.2 Cerebral perfusion pressure 
CPP was defined as the difference between mean arterial pressure (MAP) and ICP and measured 
in mmHg. MAP was measured by an arterial line or a blood pressure cuff. ICP measurements 
were obtained using the EVD. MAP and ICP were measured every two hours or more frequently 
if subjects exhibited neurologic or systemic instability. Data were available for 14 days unless 
subjects were admitted more than one day after bleeding or discharged before 14-days. Minimum 
CPP values were obtained within 12 hours prior to the time of DCI.  
6.3.3 Delayed cerebral ischemia 
DCI was defined as clinical deterioration, not attributable to rebleeding, seizures, hydrocephalus, 
or cerebral edema, accompanied by evidence of impaired cerebral blood flow (Yousef et al., 
2010). DCI was diagnosed when clinical deterioration and one or more indicator of impaired 
cerebral blood flow existed. Indications of clinical deterioration included: a) decrease in level of 
consciousness, b) new focal neurologic deficit, c) deterioration in pupillary reaction, or d) 
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worsening the NIH Stroke Scale. Cerebral blood flow assessments within 12 hours of the 
observed neurologic deterioration were evaluated (before or after).  
Cerebral blood flow was indirectly assessed using transcranial Doppler (TCD), head CT 
and CT perfusion scans, and/or cerebral angiography. Using daily TCD, impaired cerebral blood 
flow was defined as a systolic middle cerebral artery velocity >200 ml/second or Lindegaard 
ratio >3.0. Head CT and CT perfusion scans within the 12-hour temporal window of the clinical 
deterioration were reviewed for the presence of cerebral ischemia, infarction or abnormal blood 
flow. Finally, cerebral angiography studies within the same temporal window were 
independently reviewed and evaluated for vascular narrowing, with narrowing > 25% considered 
as clinically significant vasospasm.  
Subjects whose DCI status could not be determined were excluded from analysis, e.g., 
comatose and sedated and thus unable to evaluate neurologic decline.  The variable “Time to 
DCI” was defined as the number of hours from aneurysm rupture to the time of DCI diagnosis.  
6.3.4 Severity of Symptoms 
HH grade uses a 5-point scale to quantify the severity of non-traumatic SAH based on symptoms 
on admission (Hunt, Meagher, & Hess, 1966). In this analysis, HH grade was dichotomized into 
poor (grade 3-5) or good (grade 1-2).  
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6.3.5 Outcomes 
A comprehensive set of measurements that included mortality, neuropsychological, functional, 
and physical outcomes were assessed as part of the ongoing NIH study. Neuropsychological 
outcomes were assessed at 3 and 12 months for seven domains: attention, learning and memory, 
psychomotor speed, mental flexibility, executive function, visuo-spatial ability, and language 
(Table 7). Because of concerns about sample size in each domain, neuropsychological function 
was dichotomized as “impaired” vs. “not impaired”. All test scores in all domains were 
converted to z-scores. A z-score of ≤ -1.5 in at least two tests or a z-score of ≤ -2.0 in at least one 
test indicated neuropsychological impairment (Wefel et al., 2004). Functional outcomes were 
assessed using the modified Rankin scale (MRS) [good (0-2), poor (3-6)]. The Medical 
Outcomes Study 36-item Short-Form Health Survey version 2 (SF-36) physical component score 
was used to assess physical function (Ware et al., 2000). Validity and reliability of these outcome 
measures have been well established in patients with neurological injury (Hinchliffe et al., 1998; 
Ogden et al., 1993).  
6.3.6 Confounding variables   
Because higher measures of depression and anxiety have been associated with poorer scores on 
neuropsychological tests (Basso et al., 2007; Castaneda et al., 2008), we controlled for these 
variables when analyzing neuropsychological outcomes. Depressive symptoms were assessed 
using the Beck Depression Inventory II (BDI) (Arnarson et al., 2008). Anxiety was measured 
using the “State” component of the State-Trait Anxiety Inventory (STAI) (Spielberger, Gorsuch, 
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& R.E, 1970). Validity and reliability have been well established in patients with neurologic 
insults (Arnarson et al., 2008; Smeets et al., 1996). Age, years of education, HH grade, and 
aneurysm treatment method (surgical clipping vs. endovascular coiling) are often associated with 
DCI and post-aSAH outcomes (Haug et al., 2010; A. J. Molyneux et al., 2005; Yousef et al., 
2010), therefore were also included as control variables.   
6.3.7 Statistical analysis  
IBM SPSS19, Mplus6, and SAS9.2 were used to perform the analyses. Descriptive statistics 
including means, standard deviations, and percentages were used to describe the sample. Logistic 
regression was used to test the relationship between CPP and DCI. Accelerated failure time 
model was used to test whether CPP was associated with the onset of DCI. Finally, bias 
corrected bootstrapping was used to test if DCI mediates the relationship between HH grade and 
outcomes. An alpha level of 0.05 was used to indicate significance. All comparisons were 
performed a-priori, thus no correction for alpha level was made.  
6.4 RESULTS 
6.4.1 Sample characteristics  
Subjects (n=211) were relatively young (53±11 years), predominantly female (66%) and white 
(88%). The mean for the years of education was 13±2 years. Approximately, 62% underwent 
aneurysm coiling, 67% had a poor HH grade (3-5), and 42% had DCI.  DCI could not be 
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determined for 13 (6%) patients due to inability to assess neurological decline due to sedation or 
coma. The mean value for CPP was 53±17 mmHg. The mean BDI score was 10±8 at 3 months 
and 12±10 at 12 months. The mean State Anxiety score was 47±6 at 3 months and 45±6 at 12 
months.  
6.4.2 High CPP values are associated with increased risk for DCI  
Logistic regression was performed on DCI as a function of age, gender, HH grade [good (1-2) or 
poor (3-5)], aneurysm treatment option (clipping vs. coiling), and CPP (Table 8). The overall 
model significantly predicted DCI; χ2(5, N=196) = 71.43, p < 0.001, Nagelkerke R2 = .41. There 
was a significant positive relationship between CPP and DCI. For every 10 mmHg increase in 
CPP, the odds of DCI increased by 2.78 (95%CI 2.00-3.87). Furthermore, the mean value for 
CPP was significantly greater for subjects with DCI (64.6±17), compared to those without DCI 
(46±11), p<.001.  
6.4.3 High CPP values are associated with earlier onset of DCI 
The mean time for DCI diagnosis was 6±2.3 days after bleeding. This analysis controlled for age, 
gender, aneurysm repair method, and Hunt and Hess grade. Table 9 shows that the estimate of 
CPP was negative (-0.283) indicting that high CPP values are associated with shorter time to 
DCI (p<0.0001).  
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6.4.4 DCI does not mediate the relationship between HH grade and outcomes 
Data on neuropsychological outcomes were available for 61-77 subjects. Missing data resulted 
from time of recruitment (neuropsychological assessments were not initiated until 2003), loss to 
follow up, death, and refusal. Approximately one third had a poor MRS at 3 (32%) and 12 (30%) 
months and impaired neuropsychological function at 3 (33%) and 12 (17%) months. Mean SF36 
score was 20±5 and 22±5 at 3 and 12 months, respectively. Approximately, one-fourth of 
subjects were dead at 3 (26%) and 12 (29%) months. The direct effects between HH grade and 
outcomes were tested before testing the mediation effect. Mediation was tested only when the 
direct effect was significant. HH grade was significantly related to mortality and functional 
outcomes at 3 and 12 months, but not physical or neuropsychological function (controlling for 
age, aneurysm repair method, education, depression and anxiety). However, DCI did not 
significantly mediate the relationship between HH grade and functional outcome or death at both 
3 and 12 months (Table 10).  
6.5 DISCUSSION  
The primary goal of this study was to determine whether a measure of global cerebral perfusion 
can explain, in part, the pathogenesis of DCI.  Our findings indicated that CPP was positively 
associated with DCI and time to DCI. Further, the relationship between HH grade and outcomes 
was independent of DCI. To our knowledge, this was the first study to attempt to explain the 
relationship between HH grade and outcomes using DCI as a mediating variable.  
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6.5.1 The relationship between CPP and DCI 
Factors that lead to cerebral ischemia involve disruption of one or more of four mechanisms: 
pressure, chemical, metabolic, and neurogenic regulation (Pires, Dams Ramos, Matin, & 
Dorrance, 2013; Ter Laan, van Dijk, Elting, Staal, & Absalom, 2013). We targeted pressure 
regulation mechanism to investigate whether DCI is related to a perfusion pressure deficit. 
Utilizing Ohm’ and Poiseuille laws, we can infer that cerebral blood flow (CBF) is inversely 
related to cerebrovascular resistance (CVR) and positively related to CPP: CBF=CPP/CVR. 
When cerebral autoregulation is disrupted, which is common after aSAH, cerebral vessels dilate 
and CVR becomes very low. Cerebral blood flow is consequently highly dependent on CPP.  
Our findings indicated that CPP was related to DCI, but the direction of the relationship 
was not as expected. High CPP values were associated with DCI. Likely, high CPP values were, 
in part, the result of medical interventions, e.g., CSF drainage and induced hypertension and 
hypervolemia, which most subjects received prophylactically to prevent vasospasm. Because 
MAP and ICP (thus CPP) are highly manipulated at the bedside, the observed CPP trends were 
likely either a marker or complication of treatment. Potentially, patients with higher bleeding 
grades (who have higher risk for complications such as vasospasm and DCI) likely received 
more aggressive therapy. However, if this observed relationship between CPP and DCI was due 
to complications of treatment, this would raise several questions about induced hypertension. 
Current guidelines recommend use of induced hypertension to treat/prevent DCI. However, there 
are no guidelines that identify when hypertension can be therapeutic or too aggressive, or 
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whether different treatment strategies should be used with normotensive versus hypertensive 
patients. Future studies are needed to clarify these issues.  
Bijlenga and colleagues reported that aSAH patients had higher CPP values during 
vasospasm than before vasospasm as a result of Triple-H therapy (Bijlenga et al., 2010). Others 
have found that CPP <70 mmHg were associated with increased risk for brain tissue hypoxia and 
metabolic crisis (Schmidt et al., 2011). However, in these studies Triple-H therapy was used to 
treat DCI, rather than as a prophylaxis, and thus did not affect CPP values prior to DCI. In our 
subjects, induced hypertension and hypervolemia were used as prophylactic therapy after 
securing the aneurysm to prevent vasospasm.  
6.5.2 Outcomes and Severity of symptoms 
Four of the seven neuropsychological domains showed impairment (Table 7). The learning and 
memory domain had the highest prevalence of impairment, whereas executive function had the 
lowest prevalence. Others have reported a similar trend (Mayer et al., 2002). Impairment (per 
domain) ranged from 3%-23% of subjects. Others have reported a range of 14%-61% for 
impairment (Al-Khindi et al., 2010; Kreiter et al., 2002). The overall prevalence of 
neuropsychological impairment ranged from 33% to 17% at 3 and 12 months, respectively. 
Others have reported a prevalence of 27%-46% at similar time points (Haug et al., 2010; Mayer 
et al., 2002; Scott et al., 2010). Subjects’ mean BDI score indicated normal variability at 3 
months and mild mood disturbances at 12 months. However, the State Scale score of our subjects 
suggested clinically significant anxiety (score > 39 indicates significant anxiety) (Knight, Waal-
Manning, & Spears, 1983).  
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We attempted to explain the relationship between the severity of symptoms and poor 
outcomes through DCI. However, DCI did not mediate the relationship between HH grade and 
outcomes. This finding might be biased due to the missing neuropsychological function data. 
However, it suggests the relationship between HH grade and poor outcomes is either direct or 
influenced by mediators other than DCI. Other potential mediators may include delayed 
neurologic deficit, generalized cerebral edema, infarction, severity of initial bleeding, and early 
brain injury. These variables have shown strong associations with poor outcomes after aSAH 
(Cahill, Zhang, Cahill, & Zhang, 2009; Hutter et al., 1999; Kreiter et al., 2002), and thus can be 
considered as candidate mediators. Unlike DCI, delayed neurologic deficit incorporates many 
causes for clinical deterioration, such as hydrocephalus, fever, seizure, edema, and electrolytes 
abnormalities, with substantial influence on morbidity and mortality after aSAH (Diringer et al., 
2011). Therefore, delayed neurologic deficit might be an important candidate mediator. It 
remains crucial to determine mediators for poor outcomes as their identification will likely assist 
in designing interventions to improve outcomes after aSAH. 
This study had several limitations. CPP measurements were not continuous. Although 
continuous CPP measurement is more desirable, it was not feasible because ICP was measured 
by EVD. All subjects had EVDs, often used in high bleeding grades. Our results may therefore 
not apply to those without EVDs and/or low bleeding grades. We did not collect data concerning 
use of induced hypertension and hypervolemia or their intensity. Such information may have 
provided further insight into our findings. Data were collected 12 years and therefore changes in 
care may have confounded the results. We did not use any formal assessment of cerebral blood 
flow, but used surrogates such as TCD. Lastly, subjects’ neuropsychological function was 
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classified as “impaired” or “not impaired” because of concerns about sample size in each 
domain. This classification may have resulted in loss of information. Future studies with larger 
sample size will be needed to address the effect of HH on specific domain or subdomains of 
neuropsychological function.  
6.6 CONCLUSION  
Patients with DCI had higher CPP values, compared to those without DCI. For every 10 mmHg 
increase in CPP, the odds of DCI increased by 2.78. High CPP was associated with earlier onset 
of DCI. The relationship between HH grade and poor outcomes after aSAH was not mediated by 
DCI, suggesting that this relationship might be direct or due to other factors not identified in this 
study. Findings raise concerns about safety of induced hypertension and the need for studies that 
define limits for hypertension which are lacking in current guidelines.  
Source of Funding: NIH National Institute of Nursing Research R01NR004339 (P.R.S, S.M.P), 
Nightingale Award of Pennsylvania, and Neuroscience Nursing Foundation.  
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Table 7. Description of domains and tests of neuropsychological function after aSAH 
 3-month 12-month 
Domain: Test N M±SD Impaired  N M±SD Impaired  
Attention: Trail Making Test A 77 49±35 0% 63 47±36 0% 
Learning and Memory: 
• Digit Span Forward 
• Digit Span Backward  
• Logical Memory  
o Story A immediate recall 
o Story A delayed recall 
o Story B immediate recall 
o Story B second immediate recall  
o Story B delayed recall 
• Rey Complex Figure 
o Immediate recall 
o Delayed recall 
 
 
75 
75 
 
77 
76 
77 
77 
76 
 
76 
75 
 
6±1 
4±1 
 
11±4 
7±5 
10±4 
13±5 
10±6 
 
13±8 
13±8 
23%  
63 
62 
 
62 
62 
62 
61 
62 
 
-- 
-- 
 
7±1 
5±2 
 
11±5 
9±5 
9±4 
13±5 
11±5 
 
-- 
-- 
16% 
Psychomotor speed: Grooved Pegboard 
• Dominant hand  
• Non-dominant Hand  
 
 
75 
72 
 
107±50 
114±41 
0%  
62 
62 
 
95±41 
101±35 
0% 
Mental Flexibility: Trail Making Test B 
 
74 114±63 0% 60 99±55 0% 
Executive Function: Stroop Color/Word Test 
 
73 42±11 4% 61 44±12 3% 
Visuospatial ability: Rey Complex Figure Test 
• Rey Figure copy score 
 
 
77 
 
29±8 
7%  
-- 
 
-- 
-- 
Language: 
• Controlled Word Association Test  
o Number of F words  
o Number of A words  
o Number of S words  
• Animal Naming Test 
o Number of Animals 
 
 
76 
76 
76 
 
75 
 
 
9±4 
7±4 
10±4 
 
15±6 
11%  
 
62 
62 
62 
 
62 
 
 
11±5 
8±4 
11±4 
 
16±5 
8% 
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Table 8. Relationship between CPP and DCI, logistic regression  
Predictor OR 95%CI P value 
Age 0.98 0.95-1.01 0.203 
Gender (female) 1.26 0.60-2.68 0.544 
Aneurysm treatment (coiling) 1.27 0.60-2.67 0.529 
Hunt and Hess (poor 3-5) 1.89 0.89-4.00 0.097 
CPP* 2.78 2.00-3.87 <0.001 
*Odds ratio (OR) and 95%CI were calculated for every 10 mmHg 
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Table 9. Relationship between CPP and time to DCI, accelerated failure model 
Parameter Estimate E 95%CI Chi square P value 
Age 0.002 0.006 -0.001-0.013 0.09 0.76 
Gender -0.055 0.129 -0.308-0.198 0.18 0.67 
Aneurysm treatment  0.001 0.128 -0.250-0.252 0.00 0.99 
HH grade -0.359 0.147 -0.647-0.071 5.97 0.01 
CPP* -0.283 0.035 -0.352-0.214 64.72 <0.0001 
*Statistics calculated for every 10 mmHg 
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Table 10. DCI mediation effect on the relationship between HH grade and 
outcomes; bootstrap confidence interval 
   Indirect effect 
Variable Coefficient 
Structure coefficient 
 with mediator Estimate Bootstrap 95% CI 
     
3-month mortality  0.48* 0.46† 0.02 (-0.05, 0.13) 
12-month mortality  0.54* 0.55* 0.01 (-0.11, 0.08) 
3-month MRS 0.63* 0.61* 0.02 (-0.05, 0.12) 
12-month MRS 0.54* 0.53† 0.01 (-0.07, 0.11) 
*<0.001, † <0.01 
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APPENDIX B  
SUBARACHNOID HEMORRHAGE: SCALES, CLINICAL PRESENTATION, 
DIAGNOSIS, AND TREATMENT 
 SCALES FOR ASSESSING THE SEVERITY OF BLEEDING AFTER ASAH B.1
Claassen-Fisher grading scale has been introduced in 2001 as a modification for the Fisher 
grading scale which does not account for intraventricular (IVH) extension of the SAH. Unlike 
the original Fisher grade which predicts vasospasm, the Claassen-Fisher grading scale was 
introduced to predict delayed cerebral ischemia after SAH (Claassen et al., 2001).   
Table 11. Claassen-Fisher grading scale 
Grade Criteria 
0 No SAH or IVH 
1 Minimal/thin SAH but no IVH in lateral ventricles 
2 Minimal/thin SAH with IVH in both lateral ventricles  
3 Thick SAH (completely filling  ≥ cistern or fissure) without IVH in lateral ventricles  
4 Thick SAH (completely filling  ≥ cistern or fissure) with IVH in both lateral ventricles 
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World Federation of Neurological Surgeons (WFNS) uses Glasgow coma score and the 
presence/absence of motor deficit to grade the severity of subarachnoid bleed ("Report of World 
Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage 
Grading Scale," 1988). 
Table 12. WFNS grading scale 
Grade Glasgow Coma Score Presence of motor deficit 
1 15 No motor deficit 
2 13-14 No motor deficit  
3 13-14 Motor deficit is present  
4 7-12 Motor deficit is present of absent  
5 3-6 Motor deficit is present of absent  
 
 APPENDIX SUBSECTION B.2
B.2.1 Clinical manifestations and diagnostic studies 
The most common manifestation for aSAH is severe headache, present in two-thirds of patients 
and is often described as “the worst headache in life”. Headache may or may not be accompanied 
with nausea and vomiting. Other typical manifestations include decrease level of consciousness, 
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focal neurologic deficit (i.e. hemiparesis, dysphasia, visual field impairment and abnormal 
pupillary reaction), and meningismus (neck stiffness, photophobia, and headache without actual 
inflammation or infection of the meninges). Atypical signs include seizure, thunderclap 
headache, confusion, trauma that result from the loss of consciousness after aneurysm rupture, 
ataxia, nystagmus, third nerve palsy, sixth nerve palsy, retinal hemorrhage, and papilledema  
(Edlow & Caplan, 2000; Suarez et al., 2006; Togha, Sahraian, Khorram, & Khashayar, 2009; 
Vindlacheruvu & Mendelow, 2002). For patients who present with these signs and symptoms, 
non-contrast computerized tomography (CT) scan - the gold standard for diagnosing SAH- is 
indicated to rule out/confirm bleeding. If bleeding is found, then CT angiography or cerebral 
angiography is indicated to rule out/confirm cerebral aneurysm. If no aneurysms found, CT 
angiography or cerebral angiography must be repeated in 1-3 weeks followed by proper imaging 
for the brain, brain stem, and spinal cord. If the initial CT scan was negative for bleeding, a 
lumber puncture is required to test for blood in the cerebrospinal fluid (CSF). Elevated red blood 
cells or xanthochromia (yellowish appearance of the CSF) indicate bleeding in the subarachnoid 
space and thus CT/cerebral angiography will be needed to identify the source of bleeding (Suarez 
et al., 2006).   
B.2.2 Treatment 
Once the diagnosis of aSAH is confirmed, securing the aneurysm/s would be the next critical 
step. There are two major options for treating ruptured aneurysms: endovascular coiling and 
surgical clipping. In endovascular coiling a detachable platinum coil is inserted in the aneurysm 
through a wire that goes through the femoral artery (Suarez et al., 2006). A stent may be placed 
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horizontally to the blood vessel (vertical to the aneurysm) to keep the coil inside the aneurysm 
and prevent it from projecting to the circulation (Q. H. Huang et al., 2011; Hwang et al., 2011; 
Suarez et al., 2006). Aneurysm clipping involves surgical craniotomy and placing a clip on the 
neck of the aneurysm which would close the aneurysm and prevent further bleeding. The choice 
whether to use endovascular coiling or surgical clipping depends on several factors such as: 
medical condition, age, location of the aneurysm, the width of the aneurysm neck, and whether 
the aneurysm causes a mass effect on the brain tissue. Usually, younger patient, patients with 
lower Hunt and Hess grade (Klompenhouwer et al., 2011), and patients with aneurysm deep in 
the skull (basilar and vertebral aneurysm) that are hard to reach surgically are treated with 
endovascular coiling. Aneurysms with wide neck are treated with clipping because it would be 
difficult to keep the coil in place (Suarez et al., 2006). The International Subarachnoid Aneurysm 
Trial (ISAT) is a multicenter randomized controlled trial that recruited aSAH patients suitable 
for both coiling and clipping. The ISAT compared the two treatment options and found that the 
number of independent survivors was significantly higher among patients who underwent 
endovascular coiling compared to those who underwent surgical clipping. However, rebleeding 
was more frequent in patients with endovascular coiling compared to surgical clipping (A. 
Molyneux et al., 2002; A. J. Molyneux et al., 2005). Findings from the ISAT study have changed 
the practice; these changes resulted in lower mortality rate but higher cost of treatment (Qureshi 
et al., 2011). Evidence from the same trial also suggests that coiling is associated with better 
neuropsychological  functions at 1 year after bleeding (Scott et al., 2010). Therefore, 
endovascular coiling is preferred over other treatment options (Lopes, Mangubat, Keigher, & 
Cogan, 2011). 
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After securing the aneurysm with either endovascular coiling of clipping the patient need 
to be in a neuro-intensive care unit to be monitored and managed for neurologic and systemic 
complications. Neurologic complications include: rebleeding from secured aneurysm, cerebral 
vasospasm, delayed cerebral ischemia, hydrocephalus, and seizure. Systemic complications 
include: myocardial injury and arrhythmias, pulmonary edema, and deep venous thrombosis 
(Diringer et al., 2011; Rose, 2011; Suarez et al., 2006). 
The Neurocritical Care Society has published a consensus guidelines for managing 
patients with aSAH, below are the most important recommendations:  
• Patients with aSAH should be treated in large volume centers. 
• Oral nimodopine (60mg every 6 hours for 21 days after the ictus): the only treatment 
option was proven in randomized clinical trials to improve outcomes.  
• Stop using triple H therapy (hypertensive hypervolemic hemodilution) due to lack of 
supporting evidence and complications such as lowering cerebral tissue oxygen delivery.  
•  Early aneurysm repair is crucial to prevent rebleeding. 
• Baseline cardiac function evaluation; including cardiac enzymes, ECG, and 
echocardiography.  
• Maintain euvolemia and avoid hypovolemia due to increased risk of DCI. 
• Avoid hypoglycemia and keep blood sugar below 200mg/dl. 
• Treat infection and fever.  
• Incorporate measures to prevent deep venous thrombosis in the standard care of all aSAH 
patients. 
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• Continue statin therapy for aSAH patients who had it prior to the ictus.  
• Monitor patients for vasospasm and DCI.  
• Use inotrpic agents to augment blood pressure in patients with DCI who do not show 
improvement. 
• Use intraarterial vasodilators and angioplasty for DCI due to vasospasm.  
• Manage anemia, avoid blood loss from blood drawing, and consider elevating 
hemoglobin for DCI patients. 
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